News: Biotech-Cancer (June 20, 2012 archived 1 month)

June 20, 2012 Generex Announces Results of Annual Stockholders' Meeting Generex Biotechnology

June 20, 2012 Predictive Biosciences to Incorporate Next-Generation Sequencing into CertNDx Products Predictive Biosciences

June 20, 2012 Liquidia Announces Product Development Collaboration with GlaxoSmithKline Liquidia Technologies

June 20, 2012 Bristol-Myers Squibb and Emory University Announce Partnership to Advance Clinical Development of Investigational Compounds Bristol-Myers Squibb

June 20, 2012 A.P. Pharma to Present APF530 Patient-Satisfaction Data from Phase 3 Study A.P. Pharma

June 20, 2012 VG Energy to Launch First Commercial Product, LipidMax for Palm and Algae Oil Production Viral Genetics

June 20, 2012 Aptiv Solutions Showcases State of the Art Advances in the Design and Implementation of Adaptive Clinical Trials Aptiv Solutions

June 20, 2012 Cell Therapeutics Readies Commercial Launch of Pixuvri in EU; Re-Alignment of Resources and Portfolio Priorities Reduces Burn Rate by more than 30% Cell Therapeutics

June 20, 2012 AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms AcelRx Pharmaceuticals

June 20, 2012 Beyond the biggest drug maker others are topping the tables in 2018 Sanofi

June 20, 2012 Oncolytics Announces Independent Data Monitoring Committee Recommends Continued Enrollment in Phase III Study of REOLYSIN in Head and Neck Cancers Following Review of Safety Data Oncolytics Biotech

June 19, 2012 Merrimack Pharmaceuticals Receives CEO Cancer Gold Standard Accreditation 

June 19, 2012 Xcovery Appoints Expert in Targeted Cancer Therapeutics Xcovery

June 19, 2012 Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer 

June 19, 2012 Lantheus Selected to Receive $300,000 Massachusetts-Israel Innovation Partnership Grant Lantheus Medical Imaging

June 19, 2012 Novelos Therapeutics Announces Positive Initial Imaging Results In Brain Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent At UW Carbone Cancer Center Novelos Therapeutics

June 19, 2012 Pfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI (crizotinib) In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Pfizer

June 19, 2012 TransactRx Launches Immunization Plus - Pharmacy Vaccine Billing Service 

June 19, 2012 Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes Aethlon Medical

June 19, 2012 bioTheranostics Expands Its PRECIS Biomarker Profiles and Strengthens Its Industry-Leading Solution for Metastatic Cancer bioMErieux

June 19, 2012 Infinity's hedgehog project does have an end after all Subscribe to EP Vantage Infinity Pharmaceuticals

June 19, 2012 Data from Studies With Isconova's Matrix-M Published Isconova

June 19, 2012 e-Therapeutics' ETS2101 enters phase I clinical trial in brain cancer e-Therapeutics

June 19, 2012 OncoSec Announces Issuance of New Patent for Method of Use OncoSec Medical

June 19, 2012 Coronado Biosciences Receives Orphan-drug Designation from FDA for CNDO-109-activated Allogeneic Natural Killer Cells for the Treatment of AML Coronado Biosciences

June 19, 2012 Newlink Updates Enrollment Information for Its Pivotal Phase 3 Hyperacute(R) Pancreas Immunotherapy (algenpantucel-L) Trial NewLink Genetics

June 19, 2012 Femina Pharma Announces Issuance Of United States Patent 8,178,123 To Improve Drug Absorption For Cancer And HIV/AIDS Populations Femina Pharma

June 19, 2012 Asuragen Grants Armored RNA Technology License to BD Asuragen

June 19, 2012 BioSante Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement BioSante Pharmaceuticals

June 19, 2012 Angiochem Presents at the 2012 Barriers of the CNS Gordon Research Conference AngioChem

June 19, 2012 BayBio: Ten U.S. High School Students Win Biotechnology Research Competition Unassigned News Source

June 19, 2012 Roche adds to pipeline with side bet on CNS Seaside Therapeutics

June 19, 2012 ImmunoCellular to Present at 2012 AIO International Convention ImmunoCellular Therapeutics

June 19, 2012 BBVA Foundation Frontiers of Knowledge Laureates Deaton and De Quadros Defend the Advances Made in Reducing World Poverty Sabin Vaccine Institute

June 19, 2012 Pluristem Therapeutics' Cell Therapy Broadens Addressable Markets - Demonstrates Systemic Effectiveness of Intramuscular Delivery Pluristem Therapeutics

June 19, 2012 Prof. Yaron Shav-tal Receives Taubenblatt Prize for Excellence in Medical Research Bar-Ilan University

June 19, 2012 PDL to Receive Royalties on Sales of Genentech's Pertuzumab PDL BioPharma

June 19, 2012 AMRI Further Expands Discovery Capabilities in India Albany Molecular Research

June 19, 2012 XTL Biopharmaceuticals to Acquire Kitov Pharmaceuticals XTL Biopharmaceuticals

June 19, 2012 Heptares and UK Medical Research Council Extend GPCR Collaboration Heptares Therapeutics

June 20, 2012 FDA Advisory Committee Recommendation for Kyprolis Onyx Pharmaceuticals

June 19, 2012 Guided Therapeutics Announces Canadian Debut of LuViva Advanced Cervical Scan and Orders to Support Canadian Launch Guided Therapeutics

June 19, 2012 Prolias Technologies Acquires Commercial Stage microRNA Diagnostic Portfolio From Cornell University 

June 19, 2012 Citi and Maxim Health Systems Team Up to Provide Innovative Flu Care Payment Solutions 

June 19, 2012 Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs Johnson & Johnson

June 19, 2012 Cancer Research Technology Selects the Labcyte Access Laboratory Workstation to Prepare Assay-Ready Microplates for Cell-Based Screening 

June 19, 2012 EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda EpiCept

June 19, 2012 Merck Serono Announces Final Efficiency Program for Switzerland Merck KGaA

June 19, 2012 Hologic and Gen-Probe Announce Expiration of Hart-Scott-Rodino Act Waiting Period Hologic

June 18, 2012 Merrimack Pharmaceuticals Announces the Addition of Cancer Research Pioneer John Mendelsohn, M.D. to Its Board of Directors Merrimack Pharmaceuticals

June 18, 2012 Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement Debiopharm

June 18, 2012 Bharat Biotech and University of Maryland Accelerate Development of New Life Saving Conjugate Vaccine for Invasive Non-Typhoidal Salmonella (iNTS) Bharat Biotech

June 18, 2012 iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform iBio

June 18, 2012 Sinovac to Present at 55th Annual BioPharma China Convention 2012- Vaccine & Antibody Focus Sinovac Biotech

June 18, 2012 ZIOPHARM Oncology's [ZIOP] CEO, Dr. Jonathan Lewis, to Ring the NASDAQ Stock Market Opening Bell ZIOPHARM Oncology

June 18, 2012 Bavarian Nordic Awarded Contract from the U.S. Government to Advance the Development of new MVA-BN based vaccines Bavarian Nordic

June 18, 2012 Vaxin Receives Phase I SBIR Grant to Evaluate Promising New Anthrax Vaccine Vaxin

June 18, 2012 uniQure Extends Collaboration with Protein Sciences Corporation on Use of its expresSF+ Cell Line for Gene Therapy uniQure

June 18, 2012 Final Transition Milestone for Hexvix Achieved Photocure

June 18, 2012 KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million Hadasit

June 18, 2012 Texas Children's Cancer Center researchers present at world-renowned neuroblastoma conference Unassigned News Source

June 18, 2012 Galena Biopharma to Present at the 2012 AIO International Convention Galena Biopharma

June 18, 2012 Advaxis to Present at the 2012 AIO International Convention Advaxis

June 18, 2012 BARDA and Emergent BioSolutions Partner to Establish Center for Innovation in Advanced Development and Manufacturing Emergent BioSolutions

June 18, 2012 MiniVax Adds Dr. Bruce Beutler, 2011 Nobel Laureate in Medicine, as Scientific Advisor MiniVax

June 18, 2012 Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elekta's Agility Beam-shaping Device Elekta

June 18, 2012 The European Patent Office grants MolMed a new patent on its anticancer drug NGR-hTNF MolMed

June 18, 2012 Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elekta's Agility Beam-shaping Device Elekta

June 18, 2012 BioAlliance Pharma Reinforces Its Development Team with the Appointment of Louis Kayitalire, MD, as Head of Research and Development BioAlliance Pharma

June 18, 2012 MDS Researchers Join Forces to Advance Patient Treatments and Outcomes Cornell University

June 18, 2012 Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases 

June 18, 2012 InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy InnaVirVax

June 18, 2012 Genta Announces Agreement with FDA on Special Protocol Assessment of Phase 3 Trial of Tesetaxel as Initial Chemotherapy for Women with Metastatic Breast Cancer Genta

June 18, 2012 Takeda's Exclusive Distribution of Pfizer Products in Japan Takeda

June 18, 2012 RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration RayBiotech

June 18, 2012 FORMA Therapeutics Teams with TGen Drug Development (TD2) FORMA Therapeutics

June 18, 2012 CORRECTING and REPLACING Ten U.S. High School Students Win Biotechnology Research Competition Unassigned News Source

June 18, 2012 DNA Blood Test Detects Cancer Resistance Using Inostics' BEAMing Technology 

June 18, 2012 Have Americans Reached a New Era of Optimism about Aging? Pfizer

June 18, 2012 DNA Blood Test Detects Cancer Resistance Using Inostics' BEAMing Technology 

June 18, 2012 Infinity Stops Phase 2 Trials of Saridegib in Chondrosarcoma and Myelofibrosis Infinity Pharmaceuticals

June 18, 2012 Spectrum Pharmaceuticals Announces Outstanding ZEVALIN Clinical Data In Aggressive Relapsed/Refratory Lymphoma; Presented at the 17th Congress of the European Hematology Association Spectrum Pharmaceuticals

June 18, 2012 Choice of patient subgroup crucial as Synta rides the ganetespib wave Synta Pharmaceuticals

June 18, 2012 Dr. Darlene McCord To Speak At Gilda's Club Of The Quad Cities "Lunch and Learn" Hosted By Pinnaclife, Inc. Pinnaclife

June 18, 2012 European Hematology Association, American Society of Hematology, and the European Cancer Patient Coalition Issue an International Call to Action to Alleviate Drug Shortages Unassigned News Source

June 18, 2012 U.K.'s NHS Supply Chain Signs Agreement to Acquire 10 Elekta Linear Accelerator Systems for Cancer Treatment Elekta

June 18, 2012 ImmunoCellular Therapeutics Set to be Added to Russell 3000, Russell Global and Russell Microcap Indexes ImmunoCellular Therapeutics

June 18, 2012 Texas A&M System Awarded National Center for Innovation 

June 18, 2012 Study of Cell Therapeutics' Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling Cell Therapeutics

June 18, 2012 Spectros Launches OnCall Wireless Remote Access for T-Stat Spectros

June 18, 2012 Media Advisory - Oncolytics Biotech Inc. to Present at Bloom Burton & Co. Healthcare Investor Conference Oncolytics Biotech

June 18, 2012 Orexo reports regulatory approval of Edluar in Europe Orexo

June 18, 2012 Inovio Pharmaceuticals Appoints International Management Expert Dr. Angel Cabrera to its Board of Directors Inovio Pharmaceuticals

June 18, 2012 ARIAD Announces Updated Data From Pivotal PACE Trial of Ponatinib, its Investigational Pan-BCR-ABL Inhibitor ARIAD Pharmaceuticals

June 18, 2012 AHCC Research Association Facebook Fans 'Share' Health Tips For Immune Supplement Book Giveaway Unassigned News Source

June 18, 2012 Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals Vanda Pharmaceuticals

June 18, 2012 Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program Delcath Systems

June 18, 2012 Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Chang'an Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012 

June 18, 2012 Van Andel Institute Honors First Graduates Of VAI Graduate School Unassigned News Source

June 18, 2012 Serina Therapeutics to Present Novel Parkinson's Disease Treatment Serina Therapeutics

June 18, 2012 BioAdvance Announces Investment Activity in PA Life Science Companies 

June 18, 2012 Quality Health Foundation Awards Grants 

June 18, 2012 Three-Year Follow-Up Data for SPRYCEL (dasatinib) 100 mg Once-Daily Demonstrates Faster and Deeper Responses Compared With Imatinib 400 mg in Patients With Newly Diagnosed Philadelphia+ Chronic Myeloid Leukaemia in Chronic Phase 

June 18, 2012 Baylor College of Medicine and Texas Children's Hospital take part in World Rett Syndrome Congress Unassigned News Source

June 18, 2012 Raptor Pharmaceutical Completes Enrollment in Phase 2/3 Clinical Trial of RP103 for the Potential Treatment of Huntington's Disease Raptor Pharmaceutical

June 18, 2012 FDA and CMS Issue Important Updates on Makena K-V Pharmaceutical Company

June 18, 2012 FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication FluoroPharma Medical

June 18, 2012 Medical Marijuana Inc. Advisory Committee and Board of Directors Update Medical Marijuana

June 17, 2012 New Data Show Majority of Patients with aHUS Experienced Systemic Multi-Organ Complications Prior to Treatment Alexion Pharmaceuticals

June 17, 2012 Passport2Health Puts High Quality, Affordable Private Healthcare in Reach of Millions 

June 16, 2012 Pharmacyclics Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress Pharmacyclics

June 16, 2012 American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages Unassigned News Source

June 15, 2012 Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement Ascepion Pharmaceuticals

June 15, 2012 Glaxo at last gets MenHibrix approval Subscribe to EP Vantage GlaxoSmithKline

June 15, 2012 DARA BioSciences to Present Company Update at 2012 AIO Convention DARA BioSciences

June 15, 2012 Janssen Submits Additional Marketing Applications for ZYTIGA in the U.S. and European Union Johnson & Johnson

June 15, 2012 U.S. Senator John Kerry Introduces Senate Resolution Urging Federal Support To Improve Early Detection Of Prostate Cancer Unassigned News Source

June 15, 2012 Janssen Submits Additional Marketing Applications for ZYTIGA in the European Union and in the U.S. Johnson & Johnson

June 15, 2012 OncoEthix In-licenses MTPC's Cancer Compound OncoEthix

June 15, 2012 Cellerant to Present at the International Society for Stem Cell Research (ISSCR) 10th Annual Meeting in Japan Cellerant Therapeutics

June 15, 2012 How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack Unassigned News Source

June 15, 2012 Idera Pharmaceuticals to Present at the 2012 AIO International Convention Idera Pharmaceuticals

June 15, 2012 New Report Shows Ohio Clinical Trials Benefit Patients, the Economy and Science Unassigned News Source

June 15, 2012 4SC to present biomarker data for cancer drug Resminostat from Phase II SAPHIRE trial in Hodgkin's lymphoma at EHA Meeting in Amsterdam 4SC

June 15, 2012 DARA BioSciences to Present Company Update at 2012 AIO Convention DARA BioSciences

June 15, 2012 Oncolytics Biotech Inc. Announces Details of 2012 Annual and Special Meeting of Shareholders Oncolytics Biotech

June 15, 2012 MDxHealth: Extraordinary General Shareholders' Meeting MDxHealth

June 15, 2012 Denmark speeds up drug development 

June 15, 2012 Data from Sequenta's LymphoSIGHTTM Platform for the Detection of Minimal Residual Disease Presented at the European Hematology Association Meeting Sequenta

June 15, 2012 Quintessence Biosciences Meeting with Partners at 2012 AIO International Convention Quintessence Biosciences

June 15, 2012 Six-Year Follow-Up Data for SPRYCEL (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib 

June 15, 2012 Scripps Research Institute Announces Five-Year Research Collaboration with Bristol-Myers Squibb 

June 15, 2012 Colorado BioScience Association Releases 2012 Edition of Bioscience Colorado Magazine 

June 15, 2012 Hackensack University Health Network and LHP Hospital Group, Inc. Announce Ownership Approval For Mountainside Hospital 

June 14, 2012 Genelux Corporation Announces First Patient Dosed in Phase I Combination Clinical Trial of GL-ONC1 Genelux

June 14, 2012 Quest PharmaTech Initiates Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in United States Quest PharmaTech

June 14, 2012 Sabin Joins New Effort to Eliminate Measles and Rubella Sabin Vaccine Institute

June 14, 2012 GSK Receives FDA Approval for MenHibrix GlaxoSmithKline

June 14, 2012 PharmAthene Announces Further Progress In Development Of Its SparVax Anthrax Vaccine Program PharmAthene

June 14, 2012 Bonnie J. Addario Lung Cancer Living Room Goes Live Unassigned News Source

June 14, 2012 Generex Announces Publication of Abstract at ASCO 2012 Showing Potential of Antigen Express AE37 Immunotherapeutic Cancer Vaccine Technology in Prostate Cancer Generex Biotechnology

June 14, 2012 Lorus Therapeutics Announces Clinical Study Progress with its Anticancer Drug LOR-253 and Expansion to a Second Major Site Lorus Therapeutics

June 14, 2012 Immunovaccine Awards 2012 Warwick Kimmins Science Scholarship Immunovaccine

June 14, 2012 Anergis Reaches Important Milestones with Second Product Candidate AllerR Anergis

June 14, 2012 Medicago to Present at the Bloom Burton & Co. Healthcare Investment Conference Medicago

June 14, 2012 Hidden Vitamin in Milk Yields Remarkable Health Benefits Cornell University

June 14, 2012 Cellerant Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board Cellerant Therapeutics

June 14, 2012 Studies Show Significant Risk Of Skin Cancer In Skin Of Color 

June 14, 2012 ASCO Spotlight: Antibody-Drug Conjugates Are Here! 

June 14, 2012 MESUPRON Met Its Primary Objective of Demonstrating Efficacy in the Proof of Concept Phase II Breast Cancer Trial Wilex

June 14, 2012 Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting St. Louis Teens at Risk; School Nurses Rally Community in Response Unassigned News Source

June 14, 2012 Trudeau Institute announces $9 Million Translational Research Award Trudeau Institute

June 14, 2012 PanAm HIFU Opens a Prostate Cancer Treatment Center in Cancun 

June 14, 2012 Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial Based on Periodic Safety Review Sunesis Pharmaceuticals

June 14, 2012 OncoSec to Present at Upcoming Investor and Scientific Conferences OncoSec Medical

June 14, 2012 Verastem to Present at 2012 AIO International Convention Verastem

June 14, 2012 GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors GenMark Diagnostics

June 14, 2012 Sarcoma Awareness Week off to a Tee 

June 14, 2012 Sanovas Secures First U.S. Patent for Microinvasive Lung Cancer Technology Sanovas

June 14, 2012 BioNumerik Pharmaceuticals Appoints Steve Carchedi to Board of Directors BioNumerik Pharmaceuticals

June 14, 2012 Cell Therapeutics Appoints New Chief Medical Officer Cell Therapeutics

June 14, 2012 Novelos Therapeutics Closes $5.4 Million Public Offering Novelos Therapeutics

June 14, 2012 ARIAD Announces Webcast of Its Annual Shareholders Meeting ARIAD Pharmaceuticals

June 14, 2012 Sutro Licenses "Click Chemistry" from The Scripps Research Institute Sutro Biopharma

June 14, 2012 Osiris Receives Second Approval for Life-Saving Stem Cell Drug; Prochymal Granted Marketing Consent by New Zealand Osiris Therapeutics

June 14, 2012 Hemispherx's in Person Testimony at the CFSAC Spring 2012 Meeting Hemispherx Biopharma

June 14, 2012 Immunomedics to Present at 2012 Wells Fargo Securities Healthcare Conference Immunomedics

June 14, 2012 SymBio Announces Orphan Drug Designation for Treakisym (bendamustine) in Chronic Lymphocytic Leukemia (CLL) SymBio Pharmaceuticals

June 14, 2012 Prognostic Value of Cambridge Heart's MTWA Test Featured in Case of the Week in Diagnostic and Interventional Cardiology Cambridge Heart

June 14, 2012 LEO Pharma Initiates Global Search for New Partners LEO Pharma

June 14, 2012 Theraclone Sciences Announces Initiation of a Phase 1 Clinical Trial of TCN-202, an Antibody in Development for the Treatment of Human Cytomegalovirus Infection Theraclone Sciences

June 14, 2012 PDL BioPharma Completes Regular Quarterly Dividend Payment PDL BioPharma

June 14, 2012 Medigene and Azanta enter Agreement for Commercialization of Veregen in the Nordic Countries MediGene

June 14, 2012 Seattle Genetics Highlights Updated Survival Data from ADCETRIS Pivotal Trial in Patients with Relapsed or Refractory Hodgkin Lymphoma Seattle Genetics

June 14, 2012 Rheonix Highlights First Fully Automated FFPE KRAS-Biomarker Assay at BIO International Convention Rheonix

June 14, 2012 World Congress on Interventional Oncology to Present Live TheraSphere Administration Nordion

June 14, 2012 Quintiles' Patient Community Wins Second Web Health Award Quintiles

June 14, 2012 Ground-breaking Research Reveals Government Must Focus on Healthy Children's Diets to Prevent Diabetes 

June 14, 2012 Cepheid Welcomes UNITAID Commitment To Broaden Access To "Ground-Breaking" Xpert MTB/RIF Cepheid

June 14, 2012 Six new U-M stem cell lines now publicly available to help researchers find treatments for disease Unassigned News Source

June 14, 2012 DFINE Announces Completion of STAR Tumor Ablation System Phase I Release DFine

June 13, 2012 Oncolytics Biotech Inc. Announces Publication of Translational Clinical Trial Results in Science Translational Medicine Oncolytics Biotech

June 13, 2012 Clinical Trial of Human Hookworm Vaccine Begins at Children's National Medical Center Sabin Vaccine Institute

June 13, 2012 Malaria Vaccine Developer Sanaria Inc. and the Institute for Bioscience and Biotechnology Research of the University of Maryland College Park Awarded Collaborative, US $3M NIH Phase II Small Business Innovation Research Grant Sanaria

June 13, 2012 Inovio Pharmaceuticals to Participate in BIO Vaccine Panel and Present at Marcum Investor Conference Inovio Pharmaceuticals

June 13, 2012 Merrimack to Present Multiple Posters at the 2012 American Association for Cancer Research Conference "Pancreatic Cancer: Progress and Challenges" Merrimack Pharmaceuticals

June 13, 2012 Advaxis ADXS-PSA Construct Causes Significant Tumor Regression in Preclinical Prostate Cancer Study Advaxis

June 13, 2012 GTx Announces Poster Presentation on the Prevalence and Impact of Hypogonadism in Cancer Patients with Muscle Wasting from its Phase IIb Enobosarm Clinical Trial at the Endocrine Society's 2012 Annual Meeting GTx

June 13, 2012 Nuclea Biotechnologies, Inc is the Proud Sponsor of the 29th Annual Berkshire County Jimmy Fund Golf Classic to Support Research at Dana Farber Cancer Institute Nuclea Biotechnologies

June 13, 2012 Generex Announces Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012 Generex Biotechnology

June 13, 2012 Immunomedics Reports Updated Results From Phase I Pretargeting Therapy Study in Colorectal Cancer Immunomedics

June 13, 2012 The Multiple Myeloma Research Foundation (MMRF) Announces Collaboration with US Oncology Research for Landmark Clinical Study Unassigned News Source

June 13, 2012 Health Experts Highlight Growing Typhoid Pandemic in Asia Sabin Vaccine Institute

> June 13, 2012 As Pertussis Cases Climb, Survey Shows Most Parents With Young Children Overlook Vital Precaution That Helps Protect Babies Sanofi

June 13, 2012 Gold Standard Diagnostics Announces Next Generation HE4 Ovarian Cancer Biomarker Testing Solutions Gold Standard Diagnostics

June 13, 2012 Union Equity, Inc.'s Wholly Owned Subsidiary Develops Cream that Aids in Soothing the Symptoms of Chemotherapy 

June 13, 2012 Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor Astex Pharmaceuticals

June 13, 2012 Azaya Therapeutics Reports Results of Phase I Clinical Trial Azaya Therapeutics

June 13, 2012 Immunomedics Develops Potential New Treatment Regimen for Non-Hodgkin Lymphoma Immunomedics

June 13, 2012 Reagan-Udall Foundation Receives FDA Funding to Advance Regulatory Science 

June 13, 2012 PDL BioPharma Provides Second Quarter 2012 Royalty Revenue Guidance of $125 Million PDL BioPharma

June 13, 2012 Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details Prima BioMed

June 13, 2012 CytRx Set to Join the Russell Microcap Index CytRx

June 13, 2012 Aeterna Zentaris: Poster on Phase 1 Results for Perifosine in Neuroblastoma to be Presented at Upcoming Neuroblastoma Research Conference in Toronto Aeterna Zentaris

June 13, 2012 Transgenomic Announces Key Additions to Business Development Team Transgenomic

June 13, 2012 BioAlliance Pharma and Teva Announce First License Agreement for Sitavig for Israel BioAlliance Pharma

June 13, 2012 Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp. Trovagene

June 13, 2012 Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT CHOK1SV Cell Line for Therapeutic Antibody Development Lonza

June 13, 2012 ResMed Launches Narval CC Mandibular Repositioning Device in the US ResMed

June 13, 2012 Sativex Receives Regulatory Approval in Israel Neopharm Group

June 13, 2012 ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics 

June 13, 2012 Celgene Announces Additional $2.5 Billion Share Repurchase Program Celgene

June 13, 2012 Ventana takes Digital Pathology to a new level with the new VENTANA iScan HT Scanner Ventana Medical Systems

June 13, 2012 Galena Biopharma to Present at the Marcum Microcap Conference Galena Biopharma

June 13, 2012 4SC AG announces election of Dr Thomas Werner to chairman of the Supervisory Board 4SC

June 13, 2012 Roche Applied Science Launches the E-Plate Insert for Analysis of Cell-Cell Interactions using the xCELLigence System Roche

June 13, 2012 Fluidigm Introduces the C1 Single-Cell AutoPrep System to Researchers at ISSCR - Starts Early Access Program Fluidigm

June 13, 2012 DaVita Clinical Research Presented Seven HEOR Posters at ISPOR DaVita

June 13, 2012 JCVI Researchers, as Part of NIH Human Microbiome Project Consortium, Publish Papers Detailing the Variety and Abundance of Microbes Living on and in the Human Body Unassigned News Source

June 13, 2012 Advanced BioScience Laboratories to provide Cell Line Development, Process Development, and cGMP Manufacturing Services of scuPA for The University of Texas Health Science Center at Tyler 

June 12, 2012 Shanghai Genomics, Inc. Receives Patent Allowance for Pirfenidone/F647 and Its Derivative's Use in Radiation-caused Lung Injury GNI

June 12, 2012 Nymox Announces First Patient Enrollment for Phase 2 Prostate Cancer Clinical Trial Nymox Pharmaceutical

June 12, 2012 Funding the Next Scientific Breakthrough for the World's Poor Sabin Vaccine Institute

June 12, 2012 Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510 Berg Pharma

June 12, 2012 Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510 Berg Pharma

June 12, 2012 Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals Amgen

June 12, 2012 BioInvent and Cancer Research Technology enter Oncology collaboration BioInvent International

June 12, 2012 Biothera Discovers Predictive Biomarker for Cancer Drug Imprime PGG Biothera

June 12, 2012 Tokai Pharmaceuticals' Galeterone Receives Fast Track Designation from the FDA for the Treatment of Advanced Prostate Cancer Tokai Pharmaceuticals

June 12, 2012 VaxInnate Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for Pandemic Avian Flu VaxInnate

June 12, 2012 Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis Aethlon Medical

June 12, 2012 Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma Polaris Group

June 12, 2012 Multi-Center Clinical Study Intensifies First Strike at High-Risk Cancer in Kids Unassigned News Source

June 12, 2012 No cardiac benefit for Lantus but Origin confirms cancer safety Subscribe to EP Vantage Sanofi

June 12, 2012 Dermatologist, Optometrist Share Important Information About Complete UV Protection on New Edition of Healthy Vision With Dr. Val Jones Johnson & Johnson

June 12, 2012 Idera Pharmaceuticals Receives Nasdaq Listing Notice Idera Pharmaceuticals

June 12, 2012 BioScale Appoints Proteomics Leader Martin Latterich as Chief Scientific Officer BioScale

June 12, 2012 Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at Galena Biopharma

June 12, 2012 MannKind to Present at 2012 Wells Fargo Securities Healthcare Conference MannKind

June 12, 2012 Frost & Sullivan Recognizes Sanovas for its Path-Breaking Innovation in the Treatment of Pulmonary Disease 

June 12, 2012 Igenica Closes $33 Million in Series C Funding Igenica

June 12, 2012 Bionovo Selects GoIndustry DoveBid's BioPharma Exchange Program as Its Surplus Assets Sales Channel of Choice 

June 12, 2012 Medicare Limits Coverage of Popular Low-Back Pain Therapy RS Medical

June 12, 2012 Welcome to BIO-Poland Explore Our Potential 

June 12, 2012 Allergy Study Reveals Dead Sea Salt Solution as Effective as Nasal Steroids in Treating Sinus Issues, without Risks Unassigned News Source

June 12, 2012 Alnylam and Collaborators Publish New Pre-clinical Results with an RNAi Therapeutic Approach for Inducing Endogenous Erythropoiesis for the Treatment of Anemia Alnylam Pharmaceuticals

June 12, 2012 Polyphor Signs MacroFinder Collaboration with Boehringer Ingelheim Polyphor

June 12, 2012 Venus Drug to Fight Resistant 'Superbugs' Wins US Patent Venus Remedies

June 12, 2012 EpiCept Corporation to Present at 2012 AIO International Convention EpiCept

June 12, 2012 American College of Surgeons and Boston Health Care Leaders Examine How Quality Improvement Helps Curb Escalating Health Care Costs Unassigned News Source

June 12, 2012 Theragenics Announces Plans to Repurchase up to $10 Million of Its Shares in a Modified Dutch Auction Tender Offer Theragenics

June 11, 2012 Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial Sinovac Biotech

June 11, 2012 Dr. Barry Walker Appointed as Senior Director of Pre-clinical Development Aeras Global TB Vaccine Foundation

June 11, 2012 Basilea Enters Into Global Agreement With Stiefel, a GSK Company, for Toctino (alitretinoin) Basilea Pharmaceutica

June 11, 2012 Public health experts urge local authorities to maintain and improve vaccination uptake rates in the new NHS Sanofi

June 11, 2012 Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board Deciphera Pharmaceuticals

June 11, 2012 Ziopharm Oncology Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer ZIOPHARM Oncology

June 11, 2012 biOasis Receives Compelling Data from Texas Tech University on Its Herceptin BT2111 Program biOasis Technologies

June 11, 2012 Positive Results from HM781-36b Phase I Study at 2012 ASCO Hanmi Pharmaceutical

June 11, 2012 Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Atlanta Teens at Risk; School Nurses Rally Community in Response Unassigned News Source

June 11, 2012 PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued - Exclusively Licensed to Transgenomic Transgenomic

June 11, 2012 Roche scores big breast cancer win as more pivotal data approach Subscribe to EP Vantage Roche

June 11, 2012 Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO 

June 11, 2012 New Epidemiological Data Provide Additional Safety Evidence for Lantus(R) Sanofi

June 11, 2012 Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO 

June 11, 2012 Women Health Expert GC-Rise Sponsors Nationwide Anti-Cancer Campaign GC-Rise Pharmaceutical

June 11, 2012 ImaginAb and BZL Biologics Extend Licensing Relationship for Imaging Prostate-Specific Membrane Antigen (PSMA) ImaginAb

June 11, 2012 Texas A&M Chemist Builds On Natural Systems To Fight Human Disease 

June 11, 2012 Tengion Announces Continued Clinical Progress on Key Milestones for Neo-Urinary Conduit Tengion

June 11, 2012 Mevion Medical Systems Announces FDA 510(k) Clearance for the MEVION S250 Proton Therapy System Mevion Medical Systems

June 11, 2012 BioSante Pharmaceuticals Announces New LibiGel Phase III Efficacy Trials BioSante Pharmaceuticals

June 11, 2012 Immunomedics Reports Development of a New Labeling Kit for Attaching Fluorine-18 to Peptides and Temperature-sensitive Biomolecules, Including Antibodies Immunomedics

June 11, 2012 Mountain View Pharmaceuticals Receives European Patent on Potential Long-Acting Drug for Multiple Sclerosis Mountain View Pharmaceuticals

June 11, 2012 Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening New Cyclotrons in Three New Markets Cardinal Health

June 11, 2012 Henry Schein Dental Launches Likeable Dentists, Celebrates 15th Anniversary of Sullivan-Schein Dental Creation at National Sales Meeting Hepregen

June 11, 2012 Syapse Launches Application to Make Omics Data Actionable in Clinical R&D 

June 11, 2012 XTL Biopharmaceuticals Joins Two Additional Indexes on TASE XTL Biopharmaceuticals

June 11, 2012 Achillion Appoints Kurt Graves to Its Board of Directors Achillion Pharmaceuticals

June 11, 2012 Sanofi Announces Results of ORIGIN, the World's Longest and Largest Randomized Clinical Trial in Pre- and Early Diabetes Sanofi

June 11, 2012 Ethicon Endo-Surgery Continues to Drive New Research on the Impact of Metabolic and Bariatric Surgery on Diabetes, Other Disorders Johnson & Johnson

June 11, 2012 Enzo Biochem Reports Fiscal Third Quarter Results Enzo Biochem

June 11, 2012 Enterologics Comments On Increased Number Of Clinical Trials Involving Probiotics Enterologics

June 10, 2012 Ostomy Nurse Harriet Pilert Presented with Annual Great Comebacks Nurse Award at WOCN 44th Annual Conference 

June 09, 2012 FDA Approves Perjeta (Pertuzumab) for People With HER2-Positive Metastatic Breast Cancer Roche

June 09, 2012 BYDUREON Improved A1c, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients With Type 2 Diabetes Alkermes

June 09, 2012 BYETTA Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl in Patients with Type 2 Diabetes Amylin Pharmaceuticals

June 09, 2012 BYDUREON Was Associated With Significant and Sustained Glycemic Control at Four Years Alkermes

June 09, 2012 Once-Weekly BYDUREON Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir in Type 2 Diabetes Amylin Pharmaceuticals

June 09, 2012 BYDUREON Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes Amylin Pharmaceuticals

June 09, 2012 Once-weekly BYDUREON Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- Or Twice-daily Levemir in Type 2 Diabetes Alkermes

June 09, 2012 BYDUREON Was Associated with Significant and Sustained Glycemic Control at Four Years Amylin Pharmaceuticals

June 08, 2012 Coronado Biosciences Receives Notice of Allowance for First U.S. Patent Covering CNDO-109 Coronado Biosciences

June 08, 2012 Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research Elekta

June 08, 2012 First eye cancer patient at the University of Florida Proton Therapy Institute completes treatment this week Unassigned News Source

June 08, 2012 EP Vantage Interview - Immatics readying second late-stage cancer vaccine immatics biotechnologies

June 08, 2012 Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting Generex Biotechnology

June 08, 2012 Blaze Bioscience Raises $5.0 Million in Series A Financing Blaze Bioscience

June 08, 2012 Novelos Therapeutics Prices $5.4 Million Public Offering Novelos Therapeutics

June 08, 2012 Epratuzumab Results in Lupus Presented at 2012 Annual European Congress of Rheumatology Immunomedics

June 08, 2012 CLC bio delivers specialized antibody engineering and selection software for Crucell CLC bio

June 08, 2012 Novel Brain Imaging Technique Explains Why Concussions Affect People Differently Unassigned News Source

June 08, 2012 Merck Serono to Introduce RebiSlide(TM), the Rebif(R) Multidose Manual Pen-injector for Multiple Sclerosis Treatment Merck KGaA

June 08, 2012 Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal 

June 08, 2012 Post Hoc Analysis Indicated That Timing And Magnitude Of Initial Response To Certolizumab Pegol Predicted Likelihood Of Low Disease Activity At Week 28 In Patients With Active Moderate To Severe Rheumatoid Arthritis UCB

June 08, 2012 Amgen Announces Top-Line Results Of Phase 3 Sensipar/Mimpara EVOLVE Trial Amgen

June 07, 2012 Genocea Announces New Research Identifying Potential Vaccine Candidates for Chlamydia Genocea Biosciences

June 07, 2012 Celsion Announces Collaboration With the University of Oxford to Design and Execute a Clinical Trial Using Ultrasound-Guided High Intensity Focused Ultrasound and ThermoDox(R) for Metastatic Liver Cancer Celsion

June 07, 2012 Patent Application for Vacc-HIV, a Therapeutic and Potentially Preventive Hiv Vaccine Bionor Pharma

June 07, 2012 Patent Application Submitted Covering Vaccines for Flu, Hepatitis C, Cytomegalovirus and Human Papillomavirus Bionor Pharma

June 07, 2012 PharmaMar Presents New Trials With Yondelis at ASCO Grupo Zeltia

June 07, 2012 Dr. Barry Bloom Joins Aeras Board of Directors Aeras Global TB Vaccine Foundation

June 07, 2012 Expect Miracles Foundation-Financial Services Against Cancer Named to Massachusetts General Hospital Cancer Center's the one hundred List 

June 07, 2012 GenVec Announces Conditional Approval of FMD Vaccine for Cattle GenVec

June 07, 2012 Derrick L. Davis Forsyth Regional Cancer Center Earns Award for Clinical Trials Program Unassigned News Source

June 07, 2012 Industry Veteran Named CEO of Vigilant Biosciences Vigilant Biosciences

June 07, 2012 NCI Study Demonstrates Significant Overall Survival and Time-to-Next-Treatment Benefits for BiovaxID Cancer Vaccine Following Rituximab-Chemotherapy in Mantle Cell Lymphoma Study Biovest International

June 07, 2012 Advaxis Completes Enrollment of Cohort 2 in Phase 2 CIN 2/3 Study Advaxis

June 07, 2012 Foundation Medicine Enters Extensive Collaboration to Provide Genomic Information for Clinical Oncology Programs Foundation Medicine

June 07, 2012 NIH Awards $6.4 Million to Professor Mark LarchE to Investigate Mechanisms of Allergy Tolerance Generated by Circassia's ToleroMune Treatment Circassia

June 07, 2012 Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine Generex Biotechnology

June 07, 2012 PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association PharmaNet

June 07, 2012 OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers Fluorinov Pharma

June 07, 2012 CyberKnife Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting Accuray

June 07, 2012 Multiple Myeloma Research Foundation (MMRF) Awards Funding to Modulation Therapeutics for Innovative Cancer Treatment Unassigned News Source

June 07, 2012 Galectin Therapeutics to Host Symposium on Galectin Science and Therapeutic Applications September 17-19, 2012 Galectin Therapeutics

June 07, 2012 To Rest is to Rust : Financial Mail Wonderful Weekend Aspen Pharmacare

June 07, 2012 Asco EventAnalyzer - 2012 Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia Trovagene

June 07, 2012 Arno Therapeutics Announces Additional Orphan-Drug Designations for AR-42 in Europe Arno Therapeutics

June 07, 2012 ThromboGenics Receives Notice From FDA of Advisory Committee Meeting for Ocriplasmin ThromboGenics

June 07, 2012 Therapeutic focus - PD-1s show worth at Asco Subscribe to EP Vantage Bristol-Myers Squibb

June 07, 2012 Curis Announces Publication of Erivedge(TM) Data in the New England Journal of Medicine Curis

June 07, 2012 Sorrento Therapeutics Awarded Third Phase I STTR Grant Sorrento Therapeutics

June 07, 2012 Governor Patrick, Industry Representatives Join Navidea Biopharmaceuticals to Open New Business and Commercialization Facility in Andover, MA Navidea Biopharmaceuticals

June 07, 2012 Roche submits TnT-hs assay to FDA for clearance on the cobas immunoassay and Elecsys analyzers Roche

June 07, 2012 Bio-Matrix Scientific Group's Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property Bio-Matrix Scientific Group

June 07, 2012 Ferring Pharmaceuticals Donates $10 Million to the Salk Institute for Biological Studies Ferring Pharmaceuticals

June 07, 2012 Medigene Monetizes Eligard Royalty for USD 17.68 Million MediGene

June 07, 2012 BioLink's SBIR Study to Evaluate Novel Anemia Treatment BioLink Life Sciences

June 07, 2012 Cardinal Health Introduces New Technology Enhancements To Help Nuclear Medicine Departments, Imaging Centers Improve Integration, Efficiency Cardinal Health

June 07, 2012 Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain Nektar Therapeutics

June 07, 2012 QuantRx Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments QuantRx Biomedical

June 07, 2012 Two Dosing Regimens of Certolizumab Pegol Demonstrated Comparable Efficacy in Maintaining Clinical Response Versus Placebo in Patients With Moderate to Severe Rheumatoid Arthritis UCB

June 07, 2012 The Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital hosts international symposium on cognitive disorders Unassigned News Source

June 06, 2012 ANU to Grant BioDiem Exclusive License for Novel Technology to Target Infectious Diseases BioDiem

June 06, 2012 Myriad Genetics Receives the Charles R. Smart Visionary Award From the American Cancer Society Myriad Genetics

June 06, 2012 OXiGENE Announces Publication of Key Data Showing Antitumor Activity of ZYBRESTAT(R) Combined With Bevacizumab OXiGENE

June 06, 2012 Generex Announces at ASCO 2012. Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology Generex Biotechnology

June 06, 2012 Ontario, Canada's McMaster University Researchers Discover Drug Destroys Human Cancer Stem Cells but Not Healthy Ones 

June 06, 2012 Precision Therapeutics Presents GeneFx Colon Signature at the American Society of Colon and Rectal Surgery Symposium (ASCRS), the World's Largest Colorectal Conference Precision Therapeutics

June 06, 2012 UT MD Anderson research finds predictive value of circulating tumor cells in early stage breast cancer The University of Texas MD Anderson Cancer Center

June 06, 2012 Imprime PGG Binds to Adaptive Immune Cells Biothera

June 06, 2012 Major Advances in Individualized Cancer Therapy by Breakthrough Technologies Disclosed at 4th Win Symposium in Paris for the First Time 

June 06, 2012 Phase III Clinical Trial (CATS TRIAL) for Non-small-cell Lung Cancer Non-inferiority of TS-1 + Cisplatin Treatment Verified Presented to the American Society of Clinical Oncology (ASCO) Otsuka Holdings

June 06, 2012 Allegro Diagnostics to Present at 2012 Allegro Diagnostics

June 06, 2012 BIO International Convention BIO International Convention

June 06, 2012 Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Dallas-Fort Worth Teens at Risk; School Nurses Rally Community in Response Unassigned News Source

June 06, 2012 Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting Hutchison China Meditech

June 06, 2012 Debiopharm Presented Results at the ASCO 2012 Annual Meeting - Results of Phase I Study With Debio 0932, an Oral HSP90 Inhibitor in Patients With Solid Tumours Debiopharm

June 06, 2012 PacificGMP and Vasgene Therapeutics Announce Successful Manufacture of Recombinant Fusion Protein for Phase 1 Clinical Trial 

June 06, 2012 DARA BioSciences Announces Launch of Bionect for Treatment of Skin Irritation and Burns Associated With Radiation Therapy for Cancer DARA BioSciences

June 06, 2012 Brain Tumor Biotech Summit 2012 At Weill Cornell Medical College Cornell University

June 06, 2012 Affymetrix Announces Research Collaboration with Massachusetts General Hospital to Validate and Develop New Oncology Biomarker Tests Affymetrix

June 06, 2012 Medivation and Astellas Provide Update on PREVAIL Enrollment Astellas Pharma

June 06, 2012 HemCon Adds Barry Starkman as CEO HemCon Medical Technologies

June 06, 2012 Verastem to Present at the Boston CEO Conference Verastem

June 06, 2012 Silence Therapeutics Announces Safe and Effective Dose Successfully Identified in Phase I Study of Atu027 and Potential Fund Raising Silence Therapeutics

June 06, 2012 Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds from the State of Texas Ensysce Biosciences

June 06, 2012 After Capturing the U.S. Market, Frost & Sullivan Recognizes Naviscan's Pioneering Organ-Specific PET Scanner's Potential in Europe 

June 06, 2012 New STELARA Five-Year Data Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis Johnson & Johnson

June 06, 2012 Asco Interview - Seattle lays out billion dollar ambitions Seattle Genetics

June 06, 2012 Abbott Announces 10-Year Data Evaluating HUMIRA (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis Abbott Laboratories

June 06, 2012 BioCryst Presents Results from Its BCX4208 Gout Program at the Annual European Congress of Rheumatology BioCryst Pharmaceuticals

June 06, 2012 Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis Abbott Laboratories

June 06, 2012 Lilly CEO Calls for a Health Care Policy Environment That Promotes Medical Innovation Eli Lilly

June 06, 2012 Toshiba's Infinix-i Vascular X-ray Systems Help Treat Limb Ischemia for Better Patient Outcomes Toshiba

June 06, 2012 Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA (Adalimumab) in Patients with Active Peripheral Spondyloarthritis Abbott Laboratories

June 06, 2012 Weill Cornell Collaborates on Award-Winning Biomedical Product Development Cornell University

June 06, 2012 3SBio Inc. To Present at the BofAML HK / China Healthcare Corporate Day 3SBio

June 06, 2012 Study Confirms the Value of Cambridge Heart's MTWA Test as a Predictor of Life-Threatening Cardiac Events Cambridge Heart

June 06, 2012 NinePoint Medical Receives European CE Mark Approval and ISO Certification for NvisionVLE Imaging System NinePoint Medical

June 06, 2012 New Five Year Data for STELARA (Ustekinumab) Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis Johnson & Johnson

June 06, 2012 DiagnoCure 2012 Second Quarter Results DiagnoCure

June 06, 2012 Procoralan Making a Strong Entry to the new ESC Guidelines for the Management of Heart Failure Les Laboratoires Servier

June 06, 2012 The Light Study, a Long-Term Research Study of Investigational Weight Loss Drug Contrave, Begins Enrolling Patients Nationwide Unassigned News Source

June 06, 2012 Arrowhead Research Advances ARC-520 into IND-Enabling Studies for the Treatment of Hepatitis B and Provides Guidance on Development Timeline Arrowhead Research

June 06, 2012 RAPID-PsA study showed that certolizumab pegol improved the signs and symptoms of psoriatic arthritis UCB

June 06, 2012 ORENCIA (abatacept) Demonstrates Comparable Efficacy to Humira (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents Bristol-Myers Squibb

June 06, 2012 Merck Serono and Dr. Reddy's Laboratories Announce Collaboration to Develop and Commercialize Biosimilars Merck KGaA

June 06, 2012 Dr. Reddy's Laboratories Ltd. and Merck Serono Announce Collaboration to Develop and Commercialize Biosimilars Dr. Reddy's Laboratories

June 05, 2012 OPKO Health To Acquire Stake in Israeli Hepatitis B Vaccine Manufacturer OPKO Health

June 05, 2012 Oncolytics Biotech Inc. Enters into Sponsorship Agreement with NCIC CTG for Randomized Phase II Study in Non-Small Cell Lung Cancer Oncolytics Biotech

June 05, 2012 ThromboGenics and BioInvent to Regain Full Rights to TB-403 ThromboGenics

June 05, 2012 AFFiRiS AG: Parkinson's Vaccine - Worldwide First Clinical Study in Vienna AFFiRiS

June 05, 2012 Swedish Opens Comprehensive Women's Cancer Center Today Unassigned News Source

June 05, 2012 Prostate Cancer, What You Need to Know Sanofi

June 05, 2012 5-Year Cancer Survivors to Celebrate Life at Cancer Treatment Centers of America at Midwestern Regional Medical Center 

June 05, 2012 Dr. Ralph N. Purcell Responds to New Report of Orthopedic Treatment for Cancer Patients 

June 05, 2012 The Bonnie J. Addario Lung Cancer Foundation's Fifth Annual 'Addario Lectureship Award' Announced Unassigned News Source

June 05, 2012 Immunomedics Announces Results from 3 Clinical Trials Will be Presented at the 59th Annual Meeting of the Society of Nuclear Medicine Immunomedics

June 05, 2012 Prospective Study Shows Favorable Overall Survival in Cancer of Unknown Primary Patients With Therapy Directed by bioTheranostics' CancerTYPE ID bioTheranostics

June 05, 2012 Asco - Array lung data raises hopes for breakthrough in KRAS mutations Subscribe to EP Vantage Array BioPharma

June 05, 2012 Asco - Boehringer delivers well needed lung cancer win Boehringer Ingelheim

June 05, 2012 St. Jude Children's Research Hospital Celebrates 50 Years with New National PSA Campaign; Offers Glimpse of St. Jude Moments 

June 05, 2012 New Breakthrough Ion AmpliSeq Technology Delivers the Most Rapid and Comprehensive Sequencing of Gene Mutations to Advance Clinical Research Life Technologies

June 05, 2012 BioInvent and ThromboGenics to Regain Full Rights to TB-403 BioInvent International

June 05, 2012 Transgenomic Launches Breakthrough Blood-Based Cancer Gene Testing Technology at 2012 ASCO Annual Meeting Transgenomic

June 05, 2012 Generex Announces Presentation of New Immune Response Data from AE37 Phase II Breast Cancer Trial at ASCO 2012 Generex Biotechnology

June 05, 2012 AB Science Announces Publication of Three ASCO Presentations Detailing the Results of Masitinib in the Treatment of Advanced GIST AB Science

June 05, 2012 Quest PharmaTech Announces Signing of $8,000,000 Investment Agreement to Support Oregovomab Clinical Trial Programs Quest PharmaTech

June 05, 2012 ERYTECH Pharma Receives € 7 Million from OSEO to Lead the TEDAC Personalized Medicine Project in Cancer ERYtech Pharma

June 05, 2012 Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of Directors Kinex Pharmaceuticals

June 05, 2012 Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Minneapolis-St. Paul Teens at Risk; School Nurses Rally Community in Response 

June 05, 2012 JumpStart Invests $250,000 in GenomOncology 

June 05, 2012 Roche Diagnostics enters strategic alliance with med fusion that recognizes company as a Roche Molecular Center of Excellence Roche

June 05, 2012 PerkinElmer Hosts "Revolutionaries for Global Health Summit" Series PerkinElmer

June 05, 2012 Aeterna Zentaris: Phase 1 Data for Perifosine in Multiple Myeloma Published in the British Journal of Haematology Æterna Zentaris

June 05, 2012 Cabozantinib Demonstrates Durable Effects in Bone and Soft Tissue in Advanced Prostate Cancer Exelixis

June 05, 2012 Celator Pharmaceuticals Announces Presentations of Positive Survival Analyses from CPX-351 Studies at ASCO Annual Meeting Celator Pharmaceuticals

June 05, 2012 Spectrum Pharmaceuticals Announces Promising Clinical Data for ZEVALIN and Belinostat at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting Spectrum Pharmaceuticals

June 05, 2012 OncoSec Medical Inc. Enters Into Exclusive Manufacturing Agreement with VGXI Inc. for Production of Interleukin-12 Plasmid DNA OncoSec Medical

June 05, 2012 ThromboGenics and BioInvent Announce Results from Phase IIb Venous Thromboembolism Prevention Study with TB-402 ThromboGenics

June 05, 2012 PharmaGap Updates Lead Drug Status and Potential Sale PharmaGap

June 05, 2012 Post-Hoc Analysis Of Delcath's Phase 3 Trial Presented At ASCO Delcath Systems

June 05, 2012 New Phase 3 Data Show SIMPONI Intravenous Formulation Significantly Improved Rheumatoid Arthritis Signs And Symptoms In Patients With Active Disease Johnson & Johnson

June 05, 2012 Biodesix' Paul Beresford Joins 2012 AIO Panel for Personalized Medicine Commercialization Biodesix

June 05, 2012 PetCareRx Selects Whitegate PR as Agency of Record 

June 05, 2012 Merck Serono Begins Review of Proposals Received as Part of the Consultation Process With its Employees in Switzerland Merck KGaA

June 05, 2012 PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes PDL BioPharma

June 05, 2012 Medical Marijuana, Inc. Acquires 50% Stake in CanChew from Netherlands-based Sanammad Foundation Medical Marijuana

June 05, 2012 Isis Pharmaceuticals to Present a General Corporate Update at Its 2012 Annual Meeting of Stockholders and Open House Isis Pharmaceuticals

June 05, 2012 Nordion Launches New TheraSphere Preceptor Program for Doctors Nordion

June 05, 2012 Nordion Reports Second Quarter 2012 Financial Results Nordion

June 05, 2012 Celator Pharmaceuticals Announces Presentations of Positive Survival Analyses from CPX-351 Studies at ASCO Annual Meeting Celator Pharmaceuticals

June 05, 2012 Kadmon Launches 600 mg/day Ribasphere RibaPak to Provide Added Dosing Control for Triple Therapy Treatment of Chronic Hepatitis C Kadmon

June 05, 2012 Physicist and Entrepreneur Dr. Stephen Quake Honored with $500,000 Lemelson-MIT Prize 

June 05, 2012 Exonhit Receives € 1.93 Million from OSEO within the Personalized Medicine TEDAC Project in Cancer Exonhit

June 05, 2012 Fluxion Biosciences and Rubicon Genomics to Collaborate on Circulating Tumor Cell Applications 

June 05, 2012 BioLineRx Announces Receipt of Two Notices of Allowance from USPTO for Patents Covering BL-1021, an Orally Available New Chemical Entity for Treatment of Neuropathic Pain BioLineRx

June 04, 2012 MiniVax's Pneumocystis Vaccine Candidate Induces Significant anti-Pneumocystis Antibody Responses and Reduced Fungal Load MiniVax

June 04, 2012 Ventria Bioscience's InVitria Division Awarded 2-Year, $1.5 Million Grant to Develop Superior System for Cell-Based Vaccine Production Ventria Bioscience

June 04, 2012 Polynoma Commences Phase III Melanoma Vaccine Clinical Trial CK Life Sciences

June 04, 2012 Father's Day Race Benefits Prostate Cancer Awareness Unassigned News Source

June 04, 2012 Momenta Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402 Momenta Pharmaceuticals

June 04, 2012 Columbia's Cancer Center Receives $40 Million from Herbert & Florence Irving Columbia University

June 04, 2012 Immunovaccine's DPX-0907 Demonstrates Ability to Generate Promising Immune Reponses in Multiple Cancers in a Clinical Trial Presented at ASCO Annual Meeting Immunovaccine

June 04, 2012 Cellceutix CEO and Advisor Jim Boeheim Interviewed by Boston Herald About New Cancer Drug-company Cellceutix

June 04, 2012 Dr. William G. Kaelin Jr. Elected to Lilly Board of Directors Eli Lilly

June 04, 2012 Updated phase III data confirm overall survival benefit of Alpharadin in men with advanced prostate cancer that has spread to the bone Algeta

June 04, 2012 Exosome Diagnostics Signs Agreement with Life Technologies to Use Real-Time PCR Platform for Exosome Biofluid In Vitro Oncology Diagnostics Exosome Diagnostics

June 04, 2012 Agensys and Seattle Genetics Announce Interim Phase I Data from ASG-5ME Clinical Trial for Prostate Cancer Astellas Pharma

June 04, 2012 Updated Analysis of Phase III ALSYMPCA Study for Bayer's Investigational Compound Radium-223 Dichloride to be Presented at the 48th Annual ASCO Meeting Bayer

June 04, 2012 Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment Telormedix

June 04, 2012 ImmunoGen, Inc. Announces Development of Trastuzumab Emtansine for Early Stage HER2-Positive Breast Cancer ImmunoGen

June 04, 2012 Onyx Pharmaceuticals and the University of Texas MD Anderson Cancer Center Announce Strategic Alliance in Multiple Myeloma and Lymphoma Onyx Pharmaceuticals

June 04, 2012 Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment Foamix

June 04, 2012 Jennerex Presents JX-594 Clinical Data at 2012 American Society of Clinical Oncology Annual Meeting Jennerex Biotherapeutics

June 04, 2012 New Phase II data on investigational drug NGR-hTNF presented at ASCO MolMed

June 04, 2012 Afatinib* Delivers Unprecedented First Line Efficacy in Patients With EGFR Mutation Positive Lung Cancer in Registration Trial Boehringer Ingelheim

June 04, 2012 Phase III Study: Patients With Most Common Type Of Lung Cancer Lived Longer With ALIMTA-Based Continuation Maintenance Therapy Eli Lilly

June 04, 2012 Everist Genomics Announces Publication of Validation Study Confirming OncoDefender-CRC Independently Predicts Recurrence Risk for Early Stage Colorectal Cancer Patients Everist Genomics

June 04, 2012 Lung Cancer Study Showed Encouraging Results For ALIMTA-based Regimens And Full-dose Radiation Eli Lilly

June 04, 2012 First Breast Cancer Patients Treated With Minimally Invasive IceSense3 Cryoablation Procedure IceCure Medical

June 04, 2012 Baxter Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment Baxter International

June 04, 2012 Galena Biopharma Presents NeuVax Phase 1/2 Boosters Improve Disease-Free Survival at 60-Month Median Follow-Up Galena Biopharma

June 04, 2012 Data from Phase 1 and Phase 1b Studies of Newlink Genetics' IDO Pathway Inhibitor (NLG8189) Presented at 2012 ASCO Annual Meeting NewLink Genetics

June 04, 2012 Immunomedics Reports Final Survival Data from Two-part Pancreatic Cancer Study With Yttrium-90-labeled Clivatuzumab Tetraxetan Combined With Gemcitabine Immunomedics

June 04, 2012 Clinical Data Presented on Orteronel (TAK-700) without Steroids in Non-metastatic Prostate Cancer Takeda

June 04, 2012 Data from a Phase 2 Study Presented at the 2012 ASCO Annual Meeting Continues to Show Early Activity of OGX-427 in Patients with Prostate Cancer OncoGenex Pharmaceuticals

June 04, 2012 Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCO Array BioPharma

June 04, 2012 Caris Target Now ASCO Presentations Underscore Importance of Molecular Profiling in Pancreatic Cancer and Uveal Melanoma Caris Life Sciences

June 04, 2012 Clinical Data Presented on Orteronel (TAK-700) without Steroids in Non-metastatic Prostate Cancer Takeda

June 04, 2012 AVEO and Astellas Announce TAURUS Patient Preference Clinical Study Comparing Tivozanib with Sunitinib in First-Line Kidney Cancer AVEO Oncology

June 04, 2012 Afatinib demonstrates significant progression-free survival of almost one year in EGFR mutation-positive advanced NSCLC Boehringer Ingelheim

June 04, 2012 CanBas: CBP501 Met Primary Endpoint of Phase II Study in Malignant Pleural Mesothelioma CanBas

June 04, 2012 Formula Pharmaceuticals Appoints Morton Collins to Board of Directors Formula Pharmaceuticals

June 04, 2012 Goodwin Biotechnology and MD Anderson Cancer Center Collaborate on the GMP Manufacturing of a Fusion Protein Conjugate that Potentially Represents a Critical Advance in Oncology Goodwin Biotechnology

June 04, 2012 Drug combination highly effective for newly diagnosed myeloma patients Unassigned News Source

June 04, 2012 Asco - Roche scores hit with 'smart bomb' T-DM1 Subscribe to EP Vantage Roche

June 04, 2012 Emergent BioSolutions Secures Additional Funding from BARDA to Pursue Post-Exposure Prophylaxis Indication for BioThrax Emergent BioSolutions

June 04, 2012 Esperance Pharmaceuticals Presents Results From Phase 1 Study of EP-100 in Advanced, Refractory LHRH-Receptor Expressing Solid Tumors at ASCO Esperance Pharmaceuticals

June 04, 2012 Agensys and Seattle Genetics Announce Interim Phase I Data from ASG-5ME Clinical Trial for Prostate Cancer Seattle Genetics

June 04, 2012 Aeterna Zentaris: Phase 3 Data for Perifosine in Colorectal Cancer Presented at ASCO Meeting Æterna Zentaris

June 04, 2012 Fully Human Anti-PD-1 Antibody "ONO-4538/BMS-936558" Results from Phase 1 Study in Cancer Patients Published in New England Journal of Medicine (NEJM) and Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) Ono Pharmaceutical

June 04, 2012 Active Biotech's and Ipsen's Tasquinimod Shows Encouraging Overall Survival Improvement in Castrate Resistant Prostate Cancer Active Biotech

June 04, 2012 Incyte Presents Results from a Phase I Trial of INCB024360, a Novel Oral Inhibitor of Indoleamine Dioxygenase-1 (IDO1), at ASCO Incyte

June 04, 2012 Meta-analysis of Navidea Biopharmaceuticals Lymphoseek Phase 3 Data Compared to Standard of Care Techniques Published in Conjunction with the ASCO Annual Meeting Navidea Biopharmaceuticals

June 04, 2012 Asco - Metastatic prostate cancer space increasingly a battleground Subscribe to EP Vantage Dendreon

June 04, 2012 Antisense Pharma Presents Trabedersen Phase I/II Complete Data at ASCO Antisense Pharma

June 04, 2012 Alnylam Presents Data from its Phase I Extension Study with ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting Alnylam Pharmaceuticals

June 04, 2012 MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial Array BioPharma

June 04, 2012 Formula Pharmaceuticals Appoints Morton Collins to Board of Directors Formula Pharmaceuticals

June 04, 2012 Alder Biopharmaceuticals to Present at Jefferies Global Healthcare Conference Alder Biopharmaceuticals

June 04, 2012 Active Biotech's and Ipsen's Tasquinimod shows encouraging overall survival improvement in castrate resistant prostate cancer Ipsen

June 04, 2012 Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 Marshall Edwards

June 04, 2012 Synta Announces Ganetespib Presentations at the Annual Meeting of the American Society for Clinical Oncology Synta Pharmaceuticals

June 04, 2012 NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference Novavax

June 04, 2012 Phase 3 Data on Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST Onyx Pharmaceuticals

June 04, 2012 Astellas and Ambit Initiate Phase 2b Dose Finding Study of Quizartinib as Monotherapy in Relapsed Or Refractory Acute Myeloid Leukemia Ambit Biosciences

June 04, 2012 Senesco Provides SNS01-T Update on Phase 1b/2a Multiple Myeloma Trial Senesco Technologies

June 04, 2012 BioSante Pharmaceuticals, Inc. to Present at Jefferies Global Healthcare Conference BioSante Pharmaceuticals

June 04, 2012 Tekmira's LNP Technology Enables ALN-VSP Clinical Data Tekmira Pharmaceuticals

June 04, 2012 ETView Medical Ltd. Announces the Appointment of David Amar, MD, to Its Scientific Advisory Board ETView Medical

June 04, 2012 Celsion Announces Webcast Interview Featuring Professor Ronnie T.P. Poon Celsion

June 04, 2012 Astellas and Ambit Initiate Phase 2b Dose Finding Study of Quizartinib as Monotherapy in Relapsed or Refractory Acute Myeloid Leukemia Astellas Pharma

June 04, 2012 Marshall Edwards presents results of clinical trial of ME-143 Novogen

June 04, 2012 Xcovery Presents Phase 1 Clinical Results at ASCO Annual Meeting Xcovery

June 04, 2012 ImmunoGen, Inc. Announces Presentation of New Clinical Data for SAR3419 ImmunoGen

June 04, 2012 Cabozantinib Meets Primary Endpoint of Progression Free Survival in Phase 3 Pivotal Trial in Medullary Thyroid Cancer Exelixis

June 04, 2012 Pharmacyclics Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Clinical Oncology (ASCO) Annual Meeting Pharmacyclics

June 04, 2012 Orexo Acquires All US Rights for Abstral and Receives a Net Cash Consideration of MSEK 610 Orexo

June 04, 2012 BTG announces data presentation on Voraxaze (glucarpidase) at the American Society of Clinical Oncology Annual Meeting BTG

June 04, 2012 Phase III Data on Bayer's Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST Bayer

June 04, 2012 Genmab Enters DuoBody Technology Collaboration Genmab

June 04, 2012 Coronado Biosciences, Inc. Files Registration Statement for Proposed Public Offering Coronado Biosciences

June 04, 2012 PDL BioPharma to Present at the Jefferies 2012 Global Healthcare Conference PDL BioPharma

June 04, 2012 ARIAD Announces Updated Data from Pivotal PACE Trial of Ponatinib, Its Investigational pan-BCR-ABL Inhibitor ARIAD Pharmaceuticals

June 04, 2012 New Data for Jakafi (ruxolitinib) Presented at 2012 ASCO Annual Meeting Incyte

June 04, 2012 Sapio Sciences Announces Exemplar Biomarker Discovery LIMS for Personalized Medicine 

June 04, 2012 Nemeroff Law Firm Helps Defeat Louisiana Bill and Protect the Rights of Victims of Asbestos Disease 

June 04, 2012 Cell Therapeutics Completes Acquisition of Pacritinib a Highly Selective JAK2 Inhibitor Cell Therapeutics

June 04, 2012 XTL Biopharmaceuticals Files Application for Listing on the NASDAQ XTL Biopharmaceuticals

June 04, 2012 AcelRx Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference AcelRx Pharmaceuticals

June 04, 2012 CytRx to Hold Conference Call Today at 10:00 a.m. Eastern Time to Discuss Favorable Results from INNO-206 Clinical Trial in Soft Tissue Sarcoma CytRx

June 04, 2012 Orexo Acquires US Commercial Rights of Abstral and ProStrakan Acquires the Corresponding Rights in the EU and Rest of the World Kyowa Hakko Kirin

June 04, 2012 GSK Presents Positive Results for Investigational BRAF and MEK Inhibitors dabrafenib and trametinib at ASCO GlaxoSmithKline

June 04, 2012 Hybrigenics Reports Initial Results from Clinical Phase 2 Trial of Oral Inecalcitol in Moderate to Severe Psoriasis Hybrigenics

June 04, 2012 Orexo Acquires US Commercial Rights of Abstral and ProStrakan Acquires the Corresponding Rights in the EU and Rest of the World Orexo

June 04, 2012 AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million AcelRx Pharmaceuticals

June 04, 2012 EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet CIPN Program EpiCept

June 04, 2012 Oklahoma Bioscience Association to Exhibit at 2012 BIO International Convention, booth 809, Jun 18 - 21, 2012 

June 04, 2012 Carfilzomib Demonstrates Efficacy As New Frontline Treatment Regimen for Multiple Myeloma Unassigned News Source

June 04, 2012 New Comprehensive Pain Management Program Offered at Beverly Hospital at Danvers Addresses Significant Health Problem 

June 04, 2012 Bio-Path Holdings Shares Commence Trading on OTCQX, the Top Tier of the OTC Market Bio-Path Holdings

June 04, 2012 Many "Grapefruit Seed Extracts" Adulterated, says Nonprofit Research Consortium Unassigned News Source

June 04, 2012 Structural Genomics Consortium and collaborators release renewable recombinant antibodies for 12 high-impact epigenetics targets 

June 04, 2012 FibroGen Announces Preliminary Clinical Findings on the Positive Effects of FG-4592, Its Investigational HIF-PHI Therapy for Anemia, on Lowering Blood Pressure and Cholesterol in Patients With Chronic Kidney Disease FibroGen

June 04, 2012 Amylin Pharmaceuticals to Present Data on BYDUREON, BYETTA and SYMLIN at the American Diabetes Association 2012 Meeting Amylin Pharmaceuticals

June 04, 2012 ViroPharma Announces Initiation of Clinical Studies to Evaluate Maribavir for Treatment of Cytomegalovirus (CMV) Infection ViroPharma

June 03, 2012 Caris Life Sciences Announces Upcoming Launch of Caris Target Now Select Caris Life Sciences

June 03, 2012 Genentech's Targeted Investigational Breast Cancer Medicine, Trastuzumab Emtansine (T-DM1), Reduced the Risk of Cancer Worsening or Death by 35 Percent in Pivotal Phase III Trial Roche

June 03, 2012 Advaxis to Report Updated Safety, Tumor Response, and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer at ASCO Advaxis

June 03, 2012 Genentech Data Showed That People With Metastatic Colorectal Cancer Lived Longer When They Continued on Avastin Plus Chemotherapy Roche

June 03, 2012 ImmunoGen, Inc. Announces Results from Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial ImmunoGen

June 03, 2012 CytRx Announces Favorable Results from Phase 1b/2 Clinical Trial with INNO-206 CytRx

June 03, 2012 ASCO Presentations Highlight Preliminary Results of Studies with MLN9708, First Oral Proteasome Inhibitor in Clinical Trials in Multiple Myeloma Takeda

June 02, 2012 Investigational Anti-PD-1 Immunotherapy BMS-936558 Showed Clinical Activity in Phase 1 Trial of Patients with Previously-Treated Non-Small-Cell Lung Cancer, Metastatic Melanoma and Renal Cell Cancer Bristol-Myers Squibb

June 02, 2012 Interim Analysis for Bavarian Nordic's Phase 2 PROSTVAC Trial Presented at Annual ASCO Meeting Bavarian Nordic

June 02, 2012 Myriad's Lung Cancer Prognosis Test Shown to Significantly Predict Survival in Early Stage Lung Cancer Patients Myriad Genetics

June 02, 2012 OncoMed Presents First-in-Human Phase I Data on Anti-Notch2/3 Antibody at ASCO OncoMed Pharmaceuticals

June 02, 2012 GE Healthcare and Affibody AB to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer General Electric

June 02, 2012 Genentech Study Showed That Adding Avastin to Chemotherapy Cut the Risk of the Disease Getting Worse in Difficult-to-Treat Recurrent Ovarian Cancer by Half Roche

June 02, 2012 Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma to be Presented at ASCO Daiichi Sankyo

June 02, 2012 Medivation and Astellas Announce Enzalutamide Data Relating to Quality of Life Measures and Extension of Time to First Skeletal-Related Event Astellas Pharma

June 02, 2012 Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 Annual Meeting Puma Biotechnology

June 02, 2012 GE Healthcare and Affibody AB to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer Affibody

June 02, 2012 ASCO Presentations Highlight Clinical Utility of Caris Target Now in Molecular Profiling of Breast and Head and Neck Cancers Caris Life Sciences

June 02, 2012 Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma to be Presented at ASCO 

June 02, 2012 Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma to Be Presented at ASCO ArQule

June 02, 2012 Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting Oncothyreon

June 02, 2012 ZIOPHARM Oncology Completes Enrollment in PICASSO 3 Trial Evaluating Palifosfamide in Front-line Metastatic Soft Tissue Sarcoma ZIOPHARM Oncology

June 02, 2012 ZYTIGA Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer Johnson & Johnson

June 02, 2012 Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma Exelixis

June 02, 2012 Cabozantinib Demonstrates Evidence of Anti-Tumor Effects in Heavily Pretreated Patients with Hepatocellular Carcinoma Exelixis

June 02, 2012 Seattle Genetics Announces ADCETRIS Clinical Data to be Reported in Multiple Presentations at ASCO Annual Meeting Seattle Genetics

June 02, 2012 Clinical Pharmacokinetic Data on TetraLogic Pharmaceuticals' Lead Smac Mimetic Birinapant Presented at ASCO TetraLogic Pharmaceuticals

June 02, 2012 Axelar AB has Presented Phase I/II data of AXL1717 at the American Society of Clinical Oncology (ASCO) Annual Meeting Axelar

June 01, 2012 Celebrating 25 Years of Progress - Building Bridges for Cancer Surveillance 

June 01, 2012 R.A. Bloch Foundation's 2012 Cancer Survivorship Award Honors Linette Atwood 

June 01, 2012 Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction Agendia

June 01, 2012 BNC105 Trial Data Presented at American Society for Clinical Oncology (ASCO) Bionomics

June 01, 2012 More Than 550 Rita's Italian Ice Locations To Raise Funds For Alex's Lemonade Stand And The Fight Against Pediatric Cancer 

June 01, 2012 HTG Molecular Diagnostics Partners With John Wayne Cancer Institute to Commercialize Melanoma Signatures HTG Molecular Diagnostics

June 01, 2012 Starting a Clinical Study for Pancreatic Cancer Mebiopharm

June 01, 2012 the Ludwig Institute for Cancer Research Highlights a Dozen Plus Abstracts at the Annual Meeting of the American Society of Clinical Oncology Bionomics

June 01, 2012 University Hospitals Case Medical Center Experts Present at ASCO Annual Meeting Unassigned News Source

June 01, 2012 New mobile app helps doctors find clinical trials for cancer patients Eli Lilly

June 01, 2012 Genomic Health Announces Results of Eighteen Studies Covering Colon, Prostate and Breast Cancers at the American Society for Clinical Oncology (ASCO) 2012 Annual Meeting Genomic Health

June 01, 2012 immatics Presents Encouraging Overall Survival Data from a Phase 2 Study in Advanced Colorectal Cancer at the ASCO Annual Meeting immatics biotechnologies

June 01, 2012 Quest Diagnostics Launches New Molecular Test Panel for Enhanced Thyroid Cancer Detection Quest Diagnostics

June 01, 2012 bioTheranostics' CancerTYPE ID Shows High Accuracy in a Multi-Site Validation Study and Improved Performance Compared with the Standard of Care in Metastatic Tumor Diagnosis bioMErieux

June 01, 2012 Distinguished Scholars Program Launches at University Hospitals Case Medical Center's Harrington Discovery Institute 

June 01, 2012 Life Technologies Showcases Leading Technologies for Companion Diagnostic Development, Cancer Research at the ASCO Annual Meeting 2012 Life Technologies


June 01, 2012 Ribbon-cutting Ceremony to Celebrate Grand Opening of New Office and Laboratories Morphogenesis

June 01, 2012 Talon Therapeutics Announces Enrollment and Dosing of the First Patient in the Phase 3 Confirmatory Study of Marqibo(r) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (HALLMARQ Study) Talon Therapeutics

June 01, 2012 Data from an Investigator-initiated Phase 2 Study of Newlink Genetics' HyperAcute Melanoma Immunotherapy Published in 2012 ASCO Annual Meeting Abstracts NewLink Genetics

June 01, 2012 CytRx Regains NASDAQ Compliance CytRx

June 01, 2012 Researchers Present Findings on Chronic Myeloid Leukemia Treatment Patterns and Responses Involving Imatinib 

June 01, 2012 Onconova Presents Clinical Trial Data for Oral Rigosertib at ASCO Annual Meeting Onconova Therapeutics

June 01, 2012 Ethicon Endo-Surgery Highlights Comprehensive Colorectal Solutions Aimed at Improving Patient Care at ASCRS 2012 Johnson & Johnson

June 01, 2012 Inovio Implements New ATM Agreement Inovio Pharmaceuticals

June 01, 2012 Event - Origin trial to reveal if Lantus has heart Subscribe to EP Vantage Sanofi

June 01, 2012 Cyclacel Presents New Phase 2 Data of Sapacitabine for MDS at ASCO Annual Meeting Cyclacel Pharmaceuticals

June 01, 2012 Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling PharmAthene

June 01, 2012 Anacor Pharmaceuticals Appoints Paul L. Berns to Its Board of Directors Anacor Pharmaceuticals

June 01, 2012 Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO data Presented at the European Atherosclerosis Society 2012 Meeting Isis Pharmaceuticals

June 01, 2012 Amyvid (Florbetapir F 18 Injection) Now Available in Select U.S. Markets Eli Lilly

June 01, 2012 BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain NASDAQ Listing BioSante Pharmaceuticals

June 01, 2012 UCB to showcase broad immunology portfolio at EULAR 2012 UCB

June 01, 2012 Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure Aeolus Pharmaceuticals

June 01, 2012 Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid (Florbetapir F 18 Injection) Cardinal Health

May 31, 2012 Einstein Awarded $6 Million Grant to Develop New TB Vaccine Against Drug-Resistant Strains Unassigned News Source

May 31, 2012 iCo Therapeutics Receives Funding from the Government of Canada for the Pre-Clinical and Clinical Development of its Oral Amphotericin B Delivery System for the Treatment of HIV/AIDS iCo Therapeutics

May 31, 2012 BSD Medical Reports International Scientists Organize to Advance Hyperthermia as Standard Cancer Treatment in Combination with Radiation and Chemotherapy BSD Medical

May 31, 2012 Boehringer Ingelheim and CancerCare Launch My Cancer Circle Online Tool for Cancer Caregivers Boehringer Ingelheim

May 31, 2012 Precision Therapeutics Releases Data Determining the Clinical Use of ChemoFx in Helping to Select Treatment for Patients with Cervical Cancer Precision Therapeutics

May 31, 2012 N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic Solution for Precision Oncology 

May 31, 2012 Tau Therapeutics and NCI Launch Phase Ib Clinical Trial in Brain Cancer Tau Therapeutics

May 31, 2012 Genelux Corporation Announces Treatment of First Patient in Phase I/II Clinical Trial of GL-ONC1 in Advanced Peritoneal Cavity Cancers Genelux

May 31, 2012 Ventana signs exclusive licensing agreement for the commercialization of a novel BRAF V600E mutation antibody for cancer detection Ventana Medical Systems

May 31, 2012 Nearly 1,000 Medicines in Development to Help Patients in Their Fight Against Cancer  

May 31, 2012 GE Healthcare Licenses Genomic Biomarker for Lung Cancer from Insight Genetics General Electric

May 31, 2012 Biovest Interviewed by OneMedRadio; Discusses Key Milestones Expected to Establish BiovaxID as the World's First Personalized Cancer Vaccine for the Treatment of Non-Hodgkin's Lymphoma Biovest International

May 31, 2012 Insight Genetics and Kindstar Global Partner to Enhance Cancer Care in China 

May 31, 2012 Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 Otsuka Holdings

May 31, 2012 Medicago Joins the OTCQX and S&P Market Access Coverage Medicago

May 31, 2012 N-of-One Launches PrecisionWorks Cancer Informatics Platform to Help Oncologists Individualize Cancer Care 

May 31, 2012 Agendia Raises $65 Million in a Private Round of Equity Financing Agendia

May 31, 2012 Survival Data From GlobeImmune's Phase 2b Study in Patients With Resected Pancreas Cancer to Be Presented at ESMO 14th World Congress on Gastrointestinal Cancer GlobeImmune

May 31, 2012 ImmunoCellular Therapeutics to Present Long-term Survival Data from Clinical Study of ICT-107 in Glioblastoma Multiforme at American Society of Clinical Oncology Meeting ImmunoCellular Therapeutics

May 31, 2012 Genta Initiates Randomized Trial of Tesetaxel as First-Line Therapy for Women with Recurrent Breast Cancer Genta

May 31, 2012 Pre-Clinical Data Demonstrates Promising Potential of MannKind's IRE1α Inhibitor to Treat Multiple Myeloma MannKind

May 31, 2012 Oncothyreon Initiates Phase 1/2 Trial of PX-866 in Combination with Vemurafenib Oncothyreon

May 31, 2012 MEDIAN Technologies to Highlight Value of Imaging Biomarkers at the 2012 ASCO Annual Conference MEDIAN Technologies

May 31, 2012 Aeterna Zentaris: Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos One Æterna Zentaris

May 31, 2012 N-of-One Appoints Christine Cournoyer Chief Executive Officer 

May 31, 2012 GenSpera Appoints Dr. Peter E. Grebow to Its Board of Directors GenSpera

May 31, 2012 Verastem to Present at the Jefferies 2012 Global Healthcare Conference Verastem

May 31, 2012 Zyngenia, Inc. Appoints Frank Hsu, M.D., as Chief Medical Officer Zyngenia

May 31, 2012 The Multiple Myeloma Research Consortium (MMRC) Announces Oral and Poster Presentations at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting Unassigned News Source

May 31, 2012 Active Biotech to Present at the Jefferies 2012 Global Healthcare Conference Active Biotech

May 31, 2012 Quintessence Biosciences Presents on Phase I trial of Human Ribonuclease Variant, QBI-139, at the American Society of Clinical Oncology Meeting Quintessence Biosciences

May 31, 2012 Tragara's TG02 Anti-Tumor Activity is Produced via the Depletion of Anti-apoptotic Proteins Mcl-1 and XIAP Tragara Pharmaceuticals

May 31, 2012 MannKind to Present at Jefferies 2012 Global Healthcare Conference MannKind

May 31, 2012 Prima BioMed to Host Shareholder Briefing Prima BioMed

May 31, 2012 BioAlliance Pharma: Combined Shareholders Meeting BioAlliance Pharma

May 31, 2012 Novartis showcases ongoing research at ASCO to help patients fight various cancers, including updated data in advanced breast cancer Novartis

May 31, 2012 PDUFA V nears final act Subscribe to EP Vantage Novartis

May 31, 2012 Spectrum Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference Spectrum Pharmaceuticals

May 31, 2012 Silicon Biosystems Opens San Diego Laboratory to Support Expansion in US Market 

May 31, 2012 Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting 

May 31, 2012 Celldex Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference Celldex Therapeutics

May 31, 2012 Boehringer Ingelheim Expands Development Capacities With New Technical Centre Boehringer Ingelheim

May 31, 2012 BioDelivery Sciences to Present at the Jefferies 2012 Global Healthcare Conference BioDelivery Sciences International

May 31, 2012 Seattle Genetics to Present at Upcoming Investor Conferences Seattle Genetics

May 31, 2012 Photocure Announces Positive Results of Phase 2b Study Evaluating Visonac in Acne Photocure

May 31, 2012 Cell Therapeutics' Pixuvri Phase 3 Clinical Trial Results Published in The Lancet Oncology Cell Therapeutics

May 31, 2012 UCLA Longevity Center To Honor Sidney Poitier, Jane & Terry Semel, Dr. Peter Whybrow, Shlomo Rechnitz & Steve Rechnitz At 2012 ICON Awards 

May 31, 2012 Khondrion and Seahorse Bioscience in Consortium Awarded Multi-Million Euro Marie Curie Grant for Mitochondrial European Educational Training (MEET) Program Seahorse Bioscience

May 31, 2012 Webcast of Presentation at the Goldman Sachs 33rd Annual Global Healthcare Conference 

May 31, 2012 Royer Biomedical, Inc. receives FDA approval to proceed with Human Testing (IND 111446) on 5/25/2012 For its AppliGel Polymer Drug Delivery System 

May 31, 2012 Eisai Seeks Approval to Market Pariet Triple Formulation Pack in Japan for Helicobacter Pylori Eradication Eisai

May 31, 2012 Cepheid to Webcast Upcoming Financial Presentations Cepheid

May 31, 2012 InVision-Plus Benefits Shown by Study Presented at European Oncology Nursing Society RyMed Technologies

May 30, 2012 Celsion Announces Completion of Enrollment in Its Pivotal Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer Celsion

May 30, 2012 Company to Present at Rodman & Renshaw 14th Annual Healthcare Conference on How Kevetrin(TM) Has Taken Immunotherapy and Chemotherapy to a Whole New Level Cellceutix

May 30, 2012 IAVI Welcomes Louis Schwartz as Chief Financial Officer 

May 30, 2012 Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer CK Life Sciences

May 30, 2012 Boehringer Ingelheim Further Strengthens Animal Health Presence in China: Manufacturing Joint Venture for Veterinary Vaccines Boehringer Ingelheim

May 30, 2012 SymBio Announces Development Status of TREAKISYM in Refractory and Relapsed Aggressive Non-hodgkin's Lymphoma SymBio Pharmaceuticals

May 30, 2012 ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System ViewRay

May 30, 2012 West Clinic Presents Research Findings at 2012 Annual American Society for Clinical Oncology (ASCO) Meeting Unassigned News Source

May 30, 2012 Merrimack to Present Multiple Posters at the 2012 Annual Meeting of the American Society of Clinical Oncology Merrimack Pharmaceuticals

May 30, 2012 Varian Medical Systems to Showcase Oncology Practice Management Products at the 2012 Annual Meeting of the American Society of Clinical Oncology Varian Medical Systems

May 30, 2012 Varian Medical Systems Introduces Radiotherapy Treatment Planning Courses at Leading Russian Cancer Center Varian Medical Systems

May 30, 2012 Oncology Experts from Cardinal Health Specialty Solutions Share Cancer Care Research at 2012 American Society of Clinical Oncology Annual Meeting Cardinal Health

May 30, 2012 Response Genetics Announces Presentation of Lung Cancer Study Results at 2012 American Society of Clinical Oncology Annual Meeting Response Genetics

May 30, 2012 Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data for Novel Anti-Cancer Compound RX-3117 Rexahn Pharmaceuticals

May 30, 2012 GE Healthcare to Showcase Innovative Breast Cancer Solutions from Screening through Monitoring at ASCO 2012 General Electric

May 30, 2012 Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting Elekta

May 30, 2012 Genelux Corporation Announces Phase I Data Presentation at 2012 ASCO Annual Meeting of GL-ONC1, Its Oncolytic Virus Lead Product Candidate Genelux

May 30, 2012 Doug Ulman, National Cancer Survivorship Advocate, Joins Provectus Pharmaceuticals' Corporate Advisory Board Provectus Pharmaceuticals

May 30, 2012 New Survey Results from the American Society for Dermatologic Surgery Demonstrate Broad Scope of Practice for Dermatologic Surgeons 

May 30, 2012 Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer Exelixis

May 30, 2012 Medivation and Astellas Announce Initiation of Expanded Access Program for Enzalutamide (formerly MDV3100) in the United States Astellas Pharma

May 30, 2012 BioDiem Partners with leading U.S. Organization: Foundation Fighting Blindness BioDiem

May 30, 2012 AVEO Oncology to Host Conference Call and Webcast to Review Phase 3 TIVO-1 Data Presented at ASCO AVEO Oncology

May 30, 2012 Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Louisville Teens at Risk; School Nurses Rally Community in Response Unassigned News Source

May 30, 2012 Gold Standard Diagnostics Alerts Clinical Laboratories to Prepare for Continued Bordetella Pertussis "Whooping Cough" Outbreaks Gold Standard Diagnostics

May 30, 2012 Puma Biotechnology to Present at Jefferies Healthcare Conference Puma Biotechnology

May 30, 2012 Professor Carl-Henrik Heldin strengthens the Board of Kancera Kancera

May 30, 2012 Can't Prescribe the PSA Test? Flo-Med Makes It Less of a Problem BioCer Entwicklungs

May 30, 2012 California Pharmacists Endorse Proposition 29 

May 30, 2012 Ardea Biosciences Earns Milestone From Bayer HealthCare Ardea Biosciences

May 30, 2012 ARIAD to Present at Upcoming Investor Conferences ARIAD Pharmaceuticals

May 30, 2012 Menssana Research Develops Rapid Point-of-Care Breath Test for Pulmonary Tuberculosis Menssana Research

May 30, 2012 Urgent Need to Improve End Of Life Care in US 

May 30, 2012 Curis to Present at the Jefferies 2012 Global Healthcare Conference Curis

May 30, 2012 Prime Therapeutics announces enhancement to its oncology management program 

May 30, 2012 VetDC, Inc. to Present VDC-1101 Data at the 2012 American College of Veterinary Internal Medicine Forum 

May 30, 2012 Cannabis Science Creates "Cannabis Science Research Foundation" and Looks Forward to Inaugural Event in the Near Future Cannabis Science

May 30, 2012 Exelixis Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer Exelixis

May 30, 2012 Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference Array BioPharma

May 30, 2012 Morphotek Earns Prestigious Award For Innovation In Assay Development Eisai

May 30, 2012 AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing AcelRx Pharmaceuticals

May 30, 2012 Tengion Announces Reverse Stock Split Tengion

May 30, 2012 Delcath To Host Analyst Meeeting Delcath Systems

May 30, 2012 Nektar Therapeutics' President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York Nektar Therapeutics

May 30, 2012 BioTime CEO Dr. Michael West to Present at the Jefferies 2012 Global Healthcare Conference BioTime

May 30, 2012 Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference Isis Pharmaceuticals

May 30, 2012 Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia Accelrys

May 30, 2012 Synta to Present at the Jefferies 2012 Global Healthcare Conference Synta Pharmaceuticals

May 30, 2012 Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs Cell Therapeutics

May 30, 2012 Merck Serono Unveils Global Design Competition Prototype Merck KGaA

May 30, 2012 Guided Therapeutics Announces Warrant Exchange Offer Guided Therapeutics

May 30, 2012 Trovagene, Inc. Announces Pricing of Public Offering of 1,150,000 Units, Listing on NASDAQ and Effectiveness of Reverse Stock Split Trovagene

May 30, 2012 Anavex comments on President Obama's national plan to fight Alzheimer's disease Anavex Life Sciences

May 30, 2012 Glooko Launches the Glooko IR Adapter to Give ACCU-CHEK Blood Glucose Meter Customers Access to the Glooko Logbook Solution Roche

May 29, 2012 Cancerous Tumors Deliver Pro-Metastatic Information in Secreted Vesicles Cornell University

May 29, 2012 EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC) Varian Medical Systems

May 29, 2012 Karmanos Cancer Center receives HealthGrades' 2012 Outstanding Patient Experience Award Unassigned News Source

May 29, 2012 Immunovaccine to Present Clinical Data on Its DPX-0907 Cancer Vaccine at the 2012 ASCO Annual Meeting Immunovaccine

May 29, 2012 Verastem to Present Scientific Data at the 2012 ASCO Annual Meeting Verastem

May 29, 2012 First Human Study of HIV Vaccine Vacc-C5 to Begin Bionor Pharma

May 29, 2012 Bristol-Myers Squibb Announces Global Collaboration with Leading Academic Institutions to Advance Science of Immuno-Oncology Bristol-Myers Squibb

May 29, 2012 Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO) Agendia

May 29, 2012 Update Re: Late Pre-clinical Study of VAL201 ValiRx

May 29, 2012 NanoString Technologies Names Bruce Seeley Senior Vice President & General Manager, Diagnostics NanoString Technologies

May 29, 2012 Advaxis Completes Enrollment in Phase 2 Cervical Cancer Study Advaxis

May 29, 2012 World's Largest Release Of Comprehensive Human Cancer Genome Data Helps Researchers Everywhere Speed Discoveries Unassigned News Source

May 29, 2012 Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO Syndax Pharmaceuticals

May 29, 2012 Neuren Announces Cancer Xenograft Testing Results Neuren Pharmaceuticals

May 29, 2012 Genetic Susceptibility to Breast Cancer: a New, More Accurate Diagnostic Test for Mutation Screening Genomic Vision

May 29, 2012 Marshall Edwards announces first cohort of patients receive ME-344 Novogen

May 29, 2012 Agios Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference Agios Pharmaceuticals

May 29, 2012 Soricimed Biopharma Inc. Receives IND Clearance to Commence Phase I Trial of New Cancer Drug Soricimed Biopharma

May 29, 2012 OncoSec Medical Issues Letter to Shareholders OncoSec Medical

May 29, 2012 Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 Marshall Edwards

May 29, 2012 AVEO Oncology to Present at the Jefferies 2012 Global Healthcare Conference AVEO Oncology

May 29, 2012 CytRx Announces the Publication of INNO-206 Findings in Multiple Myeloma in Clinical Cancer Research CytRx

May 29, 2012 Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers Oncos Therapeutics

May 29, 2012 Recently Published Independent Research Study Detects Gene Variation In Non-Small Cell Lung Cancer Using The Sequenom Massarray Research Use System Sequenom

May 29, 2012 Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. Cannabis Science

May 29, 2012 Queensland Centre for Medical Genomics Adopts Illumina Sequencing for Australian ICGC Program Illumina

May 29, 2012 Global Health Crusader Foege Awarded Presidential Medal of Freedom Aeras Global TB Vaccine Foundation

May 29, 2012 Oncothyreon to Present at Jefferies 2012 Global Healthcare Conference Oncothyreon

May 29, 2012 Bio-Path Holdings Successfully Completes Third Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia Bio-Path Holdings

May 29, 2012 Cardinal Health Specialty Solutions Launches PathWare Decision Support Transaction Solutions Cardinal Health

May 29, 2012 OncoSec to Present at BioFinance 2012 OncoSec Medical

May 29, 2012 BioAlliance Pharma SA : Receivability of Sitavig US Registration Dossier (NDA) for the Treatment of Recurrent Orofacial Herpes Validated by the FDA BioAlliance Pharma

May 29, 2012 TRADE NEWS: Agilent Technologies Expands Catalog of SureFISH Probes to Largest Offering on the Market Agilent Technologies

May 29, 2012 Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference Isis Pharmaceuticals

May 29, 2012 Abbott to Present Wide Range of Investigational Efficacy, Safety and Health Outcomes Data on HUMIRA (Adalimumab) at the Annual Meeting of the European League Against Rheumatism Abbott Laboratories

May 29, 2012 Completed Inclusion of Patients in the Phase I/II Extension Study of Amphinex PCI Biotech

May 29, 2012 Immunomedics to Present at Jefferies 2012 Global Healthcare Conference Immunomedics

May 29, 2012 The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein 

May 29, 2012 Redx Pharma Attending Bio 2012 Aonvention Redx Pharma

May 29, 2012 Israel Makov Appointed Chairman of Sun Pharma Board Sun Pharmaceutical Industries

May 29, 2012 Onyx Pharmaceuticals to Present at Upcoming Investor Conferences Onyx Pharmaceuticals

May 29, 2012 Result of AGM ValiRx

May 29, 2012 Event - Lexicon hopes diabetes data speaks language of success Subscribe to EP Vantage Lexicon Pharmaceuticals

May 29, 2012 Genzyme and Isis Announce Filing of U.S. NDA for KYNAMRO (mipomersen sodium) in Homozygous Familial Hypercholesterolemia Isis Pharmaceuticals

May 29, 2012 NovaSom Launches to Highlight Health Consequences of Undiagnosed Sleep Apnea NovaSom

May 29, 2012 Trovagene, Inc. Announces Pricing of Public Offering of 1,150,000 Units, Listing on NASDAQ and Effectiveness of Reverse Stock Split Trovagene

May 29, 2012 Sun Pharma reports strong performance Sun Pharmaceutical Industries

May 29, 2012 Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock Cell Therapeutics

May 29, 2012 RedHill Biopharma Announces a Successful Pivotal Bioequivalence Trial with RHB-103 for the Treatment of Migraine RedHill Biopharma

May 29, 2012 Spectrum Pharmaceuticals Announces Enrollment of First Group of Patients in Phase 1 Clinical Trial of RenaZorb Spectrum Pharmaceuticals

May 28, 2012 Most Effective Strategy for Managing E. coli O157:H7 in Beef is a Combination of a Pre-Harvest Intervention and Several Processing Interventions Bioniche Life Sciences

May 28, 2012 Immunovaccine Announces Results of 2012 Annual General Meeting Immunovaccine

May 28, 2012 Shionogi Launches Injectable Analgesics for Cancer Pain, "OxiFast Injection 10mg" and "OxiFast Injection 50mg" Shionogi

May 28, 2012 Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) Acacia Pharma

May 28, 2012 New president appointed at Jubilant DraxImage Inc. Jubilant Life Sciences

May 28, 2012 Health Robotics' Upgrades its Worldwide Network in Saudi Arabia with Hospital Automation Technology (HAT) Health Robotics

May 27, 2012 3SBio Inc. To Present at the DB Access Asia Conference 2012 3SBio

May 27, 2012 Eisai Gains Positive CHMP Opinion for Fycompa (perampanel) First in a new Class of Treatment for Focal Epilepsy Eisai

May 27, 2012 Eisai Receives Positive CHMP Opinion for Zonegran (Zonisamide) Monotherapy Treatment for Epilepsy Eisai

May 26, 2012 Dendreon Announces Webcast Presentations at Upcoming Conferences Dendreon

May 26, 2012 Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet Unassigned News Source

May 25, 2012 Bionomics Launches BNC105 Ovarian Cancer Trial Bionomics

May 25, 2012 Positive Data With Experimental Nasal Pneumococcal Vaccine Eurocine Vaccines

May 25, 2012 The Pancreatic Cancer Research & Education Act (S.362) Reaches 50 Senate Co-Sponsors and Majority of Senate Help Committee Unassigned News Source

May 25, 2012 Statement of Support for New Global Vaccine Action Plan Sabin Vaccine Institute

May 25, 2012 New Drug Application Filed for Anti-Cancer Agent "Pertuzumab" for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer Chugai

May 25, 2012 Statement by Bill Gates on the Occasion of the World Health Assembly Resolutions Declaring Completion of Polio Eradication a Global Emergency and Endorsing the Global Vaccine Action Plan Sabin Vaccine Institute

May 25, 2012 Skp2 activates cancer-promoting, glucose-processing Akt The University of Texas MD Anderson Cancer Center

May 25, 2012 Government of Rwanda Introduces Merck's ROTATEQ (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus Merck & Co

May 25, 2012 Rwanda Takes Major Step to Stem Child Diarrheal Deaths 

May 25, 2012 immatics Wins 2012 TiE50 Award immatics biotechnologies

May 25, 2012 Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board Oncobiologics

May 25, 2012 Karyopharm Therapeutics Announces Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid Tumor Models at the American Society of Clinical Oncology (ASCO) Meeting Karyopharm Therapeutics

May 25, 2012 Immunomedics to Present Final Results of Pancreatic Cancer Study With Clivatuzumab at 2012 Annual Meeting of the American Society of Clinical Oncology Immunomedics

May 25, 2012 City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem Cells City of Hope

May 25, 2012 2012 Venture Forum Names PlantForm "Most Promising Technology" PlantForm

May 25, 2012 John C. Byrd, M.D. Joins Tragara Pharmaceuticals Scientific Advisory Board Tragara Pharmaceuticals

May 25, 2012 ImmunoCellular Therapeutics Receives Approval for NYSE MKT Listing ImmunoCellular Therapeutics

May 25, 2012 Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. Cannabis Science

May 25, 2012 Pfizer's Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU Pfizer

May 25, 2012 Gladstone Scientist Receives $6.3M Award from the California Institute for Regenerative Medicine The J. David Gladstone Institutes

May 25, 2012 Janssen and Johnson & Johnson to Provide Webcast Presentation of ZYTIGA (abiraterone acetate) Johnson & Johnson

May 25, 2012 PCA3 Test Featured at American Urological Association Meeting DiagnoCure

May 25, 2012 Basilea Participates in Public-private Collaboration to Tackle Antibiotic Resistance Basilea Pharmaceutica

May 25, 2012 Abstral EU Success Continues. Orexo

May 24, 2012 Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012 Immunovaccine

May 24, 2012 Interim Report for Kancera AB (publ) Q1 2012 Kancera

May 24, 2012 Genta Announces Results of Tesetaxel Confirmatory Trial in Patients with Advanced Gastric Cancer Genta

May 24, 2012 Niiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO Niiki Pharma

May 24, 2012 Novocure Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy NovoCure

May 24, 2012 Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D NanoSmart Pharmaceuticals

May 24, 2012 Innovative public-private collaboration launches to tackle antibiotic research AstraZeneca

May 24, 2012 Blueprint Medicines Welcomes Fidelity Biosciences to Investor Syndicate Blueprint medicines

May 24, 2012 Merck Serono Supports 4th International Thyroid Awareness Week Merck KGaA

May 24, 2012 Patrys Granted Key Patent for Lead Product - PAT-SM6 Patrys

May 24, 2012 Transgenomic Acquires Clinical Sample Biorepository from Gene Logic Transgenomic

May 24, 2012 True Diagnostics Receives CE Mark for TrueDX(TM) Platform & TSH Test True Diagnostics

May 24, 2012 Newport Beach Dermatologist Named Top Doctor by US News and World Report 

May 24, 2012 Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors Vertex Pharmaceuticals

May 24, 2012 NEOVA's Technology featured on THE Doctors show PhotoMedex

May 24, 2012 Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological Cancers Oryzon

May 24, 2012 Firefly BioWorks, Inc. Announces the Award of a $500K Grant from the Massachusetts Life Sciences Center 

May 24, 2012 Affitech A/S Reports Progress in R&D and Financial Results for the First Quarter of 2012 Affitech

May 24, 2012 PharmaGap Announces Conditional Approval to License Its Lead Drug and Related Intellectual Property PharmaGap

May 24, 2012 Prima BioMed Announces Changes to the Board and Senior Management Prima BioMed

May 24, 2012 Innovative Public-private Collaboration Launches to Tackle Antibiotic Research GlaxoSmithKline

May 24, 2012 Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay Cepheid

May 24, 2012 Master Healer Julie Renee Doering Hosts Health and Vitality Retreat 

May 24, 2012 Thrombotech Ltd. to Merge with D-Pharm Ltd. Hadasit

May 24, 2012 BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit Unassigned News Source

May 23, 2012 Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Bayer

May 23, 2012 New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer Onyx Pharmaceuticals

May 23, 2012 Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer Exosome Diagnostics

May 23, 2012 Dr. Ashutosh K. Tewari Receives Prestigious Gold Cystoscope Award for Contributions to Field of Urologic Oncology Cornell University

May 23, 2012 Chicago-area Pediatric Cancer Charity Gets a Surprise from Taylor Swift Unassigned News Source

May 23, 2012 Millennium and Takeda Announce Presentations for Key Investigational Molecules at American Society of Clinical Oncology Annual Meeting Takeda

May 23, 2012 Kancera´s ROR Inhibitors are Active Against Fludarabine Resistant Leukemia Kancera

May 23, 2012 Halo Healthcare, Inc., Makers of the HALO Breast Test for Risk Assessment and Early Detection of Breast Cancer, Announces New Organization Halo Healthcare

May 23, 2012 Dr. Annalisa Jenkins, Executive Vice President, Head of Global Drug Development and Medical for Merck Serono, Honored by Gilda's Club New York City Merck KGaA

May 23, 2012 Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease Celldex Therapeutics

May 23, 2012 Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent Alnylam Pharmaceuticals

May 23, 2012 Cold Spring Harbor Laboratory Joins the Illumina Genome Network Illumina

May 23, 2012 Immune Pharmaceuticals Announces Strategic Partnership With the World-renowned Weizmann Institute Immune Pharmaceuticals

May 23, 2012 Senesco's SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma Senesco Technologies

May 23, 2012 Therapure Biopharma Receives BIOTECanada Gold Leaf Award Therapure Biopharma

May 23, 2012 SoCalBio Nominates Two Southern California High School Students to Represent Region at U.S. National BioGENEius Challenge 

May 23, 2012 Seattle Genetics Announces Health Canada Accepts ADCETRIS New Drug Submission for Review Seattle Genetics

May 23, 2012 Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO data Presented at the European Atherosclerosis Society 2012 Meeting Isis Pharmaceuticals

May 23, 2012 Dr. Bob Sears Shares "What to Expect" as a New Parent 

May 23, 2012 Quest PharmaTech Announces Financial Results for 2011 Quest PharmaTech

May 23, 2012 BD Issues 2011 Sustainability Report Becton Dickinson

May 23, 2012 BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards Version 3.08 BioTime

May 23, 2012 American Academy of Environmental Medicine Calls for Immediate Caution regarding Smart Meter Installation...Cites Human Health Impacts of Chronic Exposure to Radiofrequency (RF) 

May 23, 2012 Omron Launches Sleep Monitor With ResMed Technology ResMed

May 23, 2012 Neptune's Board of Director Welcomes Dr. Harlan Waksal Neptune Technologies & Bioressources

May 23, 2012 CRN Reacts To New Study On Calcium And Heart Health 

May 23, 2012 Blood Sugar Basics Game Plan Now Available to Help Patients Tackle Type 2 Diabetes Merck & Co

May 23, 2012 Once-Daily Epilepsy Treatment now Available in Sweden Eisai

May 23, 2012 Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae Cepheid

May 23, 2012 Nevro Receives FDA Approval to Initiate Landmark U.S. Randomized Pivotal Trial of Innovative Chronic Pain Treatment Nevro

May 23, 2012 Many Pregnant Women Not Screened For Chlamydia and Gonorrhea Quest Diagnostics

May 23, 2012 Joseph H. Kanter Family Foundation Convenes Historic Learning Health System Summit; Stakeholders Collaboratively Work Toward Realizing a National-Scale Learning Health System 

May 23, 2012 NCIIA Announces Winners of the 2012 AMEidea Competition 

May 23, 2012 Data from Brentuximab Vedotin (SGN-35) Pivotal Phase II Trial in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Published in the Journal of Clinical Oncology Takeda

May 23, 2012 Amgen Announces Voting Results of Annual Meeting of Stockholders Amgen

May 23, 2012 Aetna and Silverlink Selected as Finalists in 2012 TripleTree iAwards for Innovative Program to Help Members Better Manage Diabetes 

May 22, 2012 U.S. Government Supports Phase 3 Study of Bavarian Nordic's Smallpox Vaccine Bavarian Nordic

May 22, 2012 Phase III MISSION Trial of Nexavar in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival Bayer

May 22, 2012 Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival Onyx Pharmaceuticals

May 22, 2012 HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine GeoVax Labs

May 22, 2012 University Hospitals Case Medical Center Surgical Oncologist Presents Promising Data for Novel Pancreatic Cancer Vaccine Unassigned News Source

May 22, 2012 Wellstat Grants BTG European Distribution Rights to Investigational Antidote for 5-FU Overexposure Wellstat Group

May 22, 2012 DSMB Recommends Continuation of Phase 3 Trial of HA-irinotecan in Colorectal Cancer Alchemia

May 22, 2012 Piramal Healthcare to present Phase I data for oral anticancer molecule at the American Society for Clinical Oncology (ASCO) Annual Meeting Piramal Healthcare

May 22, 2012 BiovaxID Personalized Lymphoma Vaccine is Featured in Article Published in Scrip Intelligence Biovest International

May 22, 2012 immatics at CIMT Annual Meeting 2012 Starting Tomorrow in Mainz, Germany immatics biotechnologies

May 22, 2012 Sixty-fifth World Health Assembly Focuses on Universal Coverage of Healthcare Sabin Vaccine Institute

May 22, 2012 Daiichi Sankyo and the National Cancer Center Form Comprehensive Research Alliance Daiichi Sankyo

May 22, 2012 Data Presented Shows That Hexvix Cystoscopy Significantly Improves Time to Recurrence of Bladder Cancer Photocure

May 22, 2012 Sativex Starts a Third Phase III Clinical Trial in Cancer Pain Almirall

May 22, 2012 Mirna Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate Mirna Therapeutics

May 22, 2012 Tesetaxel Results as Initial Chemotherapy for Women with Recurrent Breast Cancer to be Highlighted at ASCO Genta

May 22, 2012 Data from NewLink Genetics Phase 2 Trial of Its Hyperacute(R) Pancreas (Algenpantucel-L Immunotherapy to be Presented at the 2012 Digestive Disease Week NewLink Genetics

May 22, 2012 Scientists Unravel Role of Fusion Gene in Prostate Cancer Cornell University

May 22, 2012 Immunovaccine to Host Annual General Meeting Immunovaccine

May 22, 2012 Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement Accuray

May 22, 2012 Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement Accuray

May 22, 2012 Vical Announces Publication of Herpes Simplex Vaccine Mouse Study Data Vical

May 22, 2012 Third Phase III Sativex Cancer Pain Trial Commences GW Pharmaceuticals

May 22, 2012 ABPI and Teenage Cancer Trust CEOs in Keynote Debate at Patient Summit 2012 

May 22, 2012 Genetic Technologies Provides BREVAGen(TM) Sales and Reimbursement Update Genetic Technologies

May 22, 2012 Therapeutic focus - Phase III lung cancer pipeline loses Nexavar as novel agents approach Subscribe to EP Vantage Merck KGaA

May 22, 2012 Genesis Biopharma Mentioned Favorably in BioMedReports Article Genesis Biopharma

May 22, 2012 Bavarian Nordic A/S - Interim Report for the Period 1 January to 31 March 2012 Bavarian Nordic

May 22, 2012 Pharmacokinetics Parameters of Sunshine Biopharma's Lead Anti-Cancer Compound Exceed Expectations Sunshine BioPharma

May 22, 2012 Talon Therapeutics Appoints Head of Commercial Operations and Planning Talon Therapeutics

May 22, 2012 Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association Pharmacyclics

May 22, 2012 Diamyd Medical's Phase II Study in Cancer Pain Fully Recruited Diamyd Medical

May 22, 2012 As Obesity Epidemic Soars, Scientists and Researchers Explore Connections to Other Diseases 

May 22, 2012 Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders Galectin Therapeutics

May 22, 2012 Celtic Pharma Announces Successful Completion of Phase I/II Study of Xerecept in Pediatric Patients With Cerebral Tumors Celtic Pharma

May 22, 2012 MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL MorphoSys

May 22, 2012 Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan. Jiangsu Hengrui Medicine

May 22, 2012 US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through India Everist Genomics

May 22, 2012 US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through India Everist Genomics

May 22, 2012 Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation Avaxia Biologics

May 22, 2012 Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept in Pediatric Patients with Cerebral Tumors Celtic Pharma

May 22, 2012 Active gets boost as pipeline hopes rise Subscribe to EP Vantage Active Biotech

May 22, 2012 MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL Xencor

May 22, 2012 e-Therapeutics' Preliminary Results for the Year Ended 31 January 2012 e-Therapeutics

May 22, 2012 Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy General Electric

May 22, 2012 MagForce Signs Distribution Agreement With Leading Russian Medical Device Distribution Company DELRUS MagForce

May 22, 2012 BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases BioTime

May 22, 2012 New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management Prometheus Laboratories

May 22, 2012 Celgene Corporation to Present at Sanford C. Bernstein's 28th Annual Strategic Decisions Conference Celgene

May 22, 2012 Minnesota hospital programs, leaders honored 

May 22, 2012 Seahorse Bioscience raises $9.4M Seahorse Bioscience

May 22, 2012 Texas Children's Fetal Center First in Southwestern United States to Perform Experimental In-Utero Procedure to Treat Congenital Diaphragmatic Hernia Unassigned News Source

May 22, 2012 Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma Boehringer Ingelheim

May 21, 2012 Cellceutix Files Amended IND With FDA for Its Novel p53 "guardian Angel" Anti-cancer Drug Cellceutix

May 21, 2012 Lung Cancer Alliance Reiterates Its Strong Support For Scientifically Validated CT Screening For Lung Cancer - Concerned That Recent Study Will Slow At Risk Consumer Access To Life Saving Care Unassigned News Source

May 21, 2012 Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients Ventana Medical Systems

May 21, 2012 Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing Unassigned News Source

May 21, 2012 Peregrine Announces Positive Top-line Data from Randomized, Double-blind Bavituximab Phase II Trial in Second-line Non-small Cell Lung Cancer Peregrine Pharmaceuticals

May 21, 2012 Cook Expands Line of Endoscopic Ultrasound Needles with Addition of Smallest Gage on the Market Designed for Histological and Cytological Samples Cook Group

May 21, 2012 BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. BioDelivery Sciences International

May 21, 2012 Be Sun Safe and Enjoy the Summer - Prevent Skin Cancer Now! Crawford Healthcare

May 21, 2012 Three Abstracts on the ChemoFx Drug Response Marker Accepted by ASCO Precision Therapeutics

May 21, 2012 Study Results of Novocure's NovoTTF Pivotal Phase 3 Trial Published in European Journal of Cancer NovoCure

May 21, 2012 Study Results of Novocure's NovoTTF Pivotal Phase 3 Trial Published in European Journal of Cancer NovoCure

May 21, 2012 600 Patients Recruited in Active Biotech's and Ipsen's Tasquinimod Clinical Phase III Study Active Biotech

May 21, 2012 Viatronix V3D-Colon Platform Utilized for Key Laxative Free CT Colonography Trial Viatronix

May 21, 2012 Genesis Biopharma Issues Letter To Shareholders Genesis Biopharma

May 21, 2012 AQUA Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated HistoRx

May 21, 2012 Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting Dendreon

May 21, 2012 Caris Target Now Data to be Showcased at ASCO 2012 Caris Life Sciences

May 21, 2012 DARA BioSciences Reports Financial Results for the First Quarter 2012 And Provides Key Highlights of the Company's Business Milestones DARA BioSciences

May 21, 2012 A New Diagnostic Tool Increases the Value of Kancera´s ROR Technology Kancera

May 21, 2012 The Ohio State University to Place Final Beam in Topping Out Ceremony of $1.1 Billion Hospital Expansion 

May 21, 2012 A Conversation With A Living Legend sponsors lead 23rd annual fundraising efforts for UT MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center

May 21, 2012 Royal Melbourne Hospital: First Public Hospital in Australia to Adopt New Technology for Brain Tumour Surgery Specialised Therapeutics

May 21, 2012 High School Students Named Winners in Local Biotechnology Research Competition 

May 21, 2012 600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study Ipsen

May 21, 2012 Cellectis stem cells today proudly announces the launch of the world's very first human iPS cell-derived hepatocyte product Cellectis

May 21, 2012 BSD Reports Increasing Role of Microwave Ablation Featured at European Conference on Interventional Oncology (ECIO) BSD Medical

May 21, 2012 Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors Apollo Endosurgery

May 21, 2012 Makucell Appoints International Life Sciences Business Leader and Chairman of the Pasadena Angels, Kevin J. Scanlon, Ph.D., to Its Board of Advisors 

May 21, 2012 Medivation and Astellas Announce Submission of New Drug Application for Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated with Chemotherapy Astellas Pharma

May 21, 2012 VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory Bowel Disease at Digestive Disease Week (DDW) 2012 VBL Therapeutics

May 21, 2012 Medivation and Astellas Announce Submission of New Drug Application for Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated With Chemotherapy Medivation

May 21, 2012 Elevate Provides Remote Access to Personal Health Records Using 

May 21, 2012 Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement 

May 21, 2012 GenVec Appoints Cynthia Collins as President and CEO GenVec

May 21, 2012 BioTime Completes Merger of XenneX, Inc. into LifeMap Sciences, Inc. BioTime

May 21, 2012 Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR Scan KRAS Kit in Europe Transgenomic

May 21, 2012 Heat Biologics, Inc.: Series A $2.8M Heat Biologics

May 21, 2012 Leading Technology Incubator Honors Extraordinary Entrepreneurs 

May 21, 2012 Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD) Sucampo Pharmaceuticals

May 21, 2012 New Phase 3 Study Results Show Anti-TNF SIMPONI Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis Johnson & Johnson

May 21, 2012 Achillion Announces Additional Proof-of-concept Data With ACH-2684 for the Treatment of Hepatitis C Achillion Pharmaceuticals